UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number:
(Exact name of registrant as specified in its charter)
|
||
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
(Address of principal executive offices, including zip code)
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading symbol(s) |
|
Name of each exchange on which registered |
|
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
|
☒ |
Accelerated Filer |
|
☐ |
|
Non-accelerated Filer |
|
☐ |
Smaller Reporting Company |
|
|
|
|
|
Emerging Growth Company |
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
As of November 30, 2023, the registrant had
TABLE OF CONTENTS
|
|
|
PAGE |
PART I. |
|
|
|
|
|
|
|
|
Item 1 |
6 |
|
|
|
|
|
|
Item 2 |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
35 |
|
|
|
|
|
Item 3 |
53 |
|
|
|
|
|
|
Item 4 |
53 |
|
|
|
|
|
PART II. |
|
|
|
|
|
|
|
|
Item 1 |
56 |
|
|
|
|
|
|
Item 1A |
56 |
|
|
|
|
|
|
Item 2 |
56 |
|
|
|
|
|
|
Item 3 |
56 |
|
|
|
|
|
|
Item 4 |
56 |
|
|
|
|
|
|
Item 5 |
56 |
|
|
|
|
|
|
Item 6 |
57 |
|
|
|
|
|
58 |
|||
59 |
3
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains express and implied forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), which statements involve substantial risks and uncertainties. Other than statements of historical fact, all statements contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations and financial position, our business strategy and plans and our objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "potentially," "estimate," "continue," "anticipate," "plan," "intend," "could," "would," "expect," or words or expressions of similar substance or the negative thereof, that convey uncertainty of future events or outcomes are intended to identify forward-looking statements. Forward-looking statements included in this Quarterly Report on Form 10-Q include, but are not limited to, statements regarding:
4
We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs in light of the information currently available to us. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described under the heading "Risk Factors" in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended July 31, 2023. Moreover, we operate in a very competitive and rapidly changing environment and new risks emerge from time to time. It is not possible for us to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained or implied in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and trends discussed in this Quarterly Report on Form 10-Q may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.
You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, performance, or events and circumstances reflected in the forward-looking statements will be achieved or will occur. The forward-looking statements in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation, and expressly disclaim any obligation, to update, alter or otherwise revise or publicly release the results of any revision to these forward-looking statements to reflect new information or the occurrence of unanticipated or subsequent events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements.
5
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
6
NUTANIX, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
|
|
As of |
|
|||||
|
|
July 31, |
|
|
October 31, |
|
||
|
|
(in thousands, except per share data) |
|
|||||
Assets |
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
|
|
$ |
|
||
Short-term investments |
|
|
|
|
|
|
||
Accounts receivable, net of allowances of $ |
|
|
|
|
|
|
||
Deferred commissions—current |
|
|
|
|
|
|
||
Prepaid expenses and other current assets |
|
|
|
|
|
|
||
Total current assets |
|
|
|
|
|
|
||
Property and equipment, net |
|
|
|
|
|
|
||
Operating lease right-of-use assets |
|
|
|
|
|
|
||
Deferred commissions—non-current |
|
|
|
|
|
|
||
Intangible assets, net |
|
|
|
|
|
|
||
Goodwill |
|
|
|
|
|
|
||
Other assets—non-current |
|
|
|
|
|
|
||
Total assets |
|
$ |
|
|
$ |
|
||
Liabilities and Stockholders’ Deficit |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
|
|
$ |
|
||
Accrued compensation and benefits |
|
|
|
|
|
|
||
Accrued expenses and other current liabilities |
|
|
|
|
|
|
||
Deferred revenue—current |
|
|
|
|
|
|
||
Operating lease liabilities—current |
|
|
|
|
|
|
||
Total current liabilities |
|
|
|
|
|
|
||
Deferred revenue—non-current |
|
|
|
|
|
|
||
Operating lease liabilities—non-current |
|
|
|
|
|
|
||
Convertible senior notes, net |
|
|
|
|
|
|
||
Other liabilities—non-current |
|
|
|
|
|
|
||
Total liabilities |
|
|
|
|
|
|
||
|
|
|
|
|
|
|||
Stockholders’ deficit: |
|
|
|
|
|
|
||
Preferred stock, par value of $ |
|
|
|
|
|
|
||
Common stock, par value of $ |
|
|
|
|
|
|
||
Additional paid-in capital |
|
|
|
|
|
|
||
Accumulated other comprehensive loss |
|
|
( |
) |
|
|
( |
) |
Accumulated deficit |
|
|
( |
) |
|
|
( |
) |
Total stockholders’ deficit |
|
|
( |
) |
|
|
( |
) |
Total liabilities and stockholders’ deficit |
|
$ |
|
|
$ |
|
See the accompanying notes to condensed consolidated financial statements.
7
NUTANIX, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands, except per share data) |
|
|||||
Revenue: |
|
|
|
|
|
|
||
Product |
|
$ |
|
|
$ |
|
||
Support, entitlements and other services |
|
|
|
|
|
|
||
Total revenue |
|
|
|
|
|
|
||
Cost of revenue: |
|
|
|
|
|
|
||
Product |
|
|
|
|
|
|
||
Support, entitlements and other services |
|
|
|
|
|
|
||
Total cost of revenue |
|
|
|
|
|
|
||
Gross profit |
|
|
|
|
|
|
||
Operating expenses: |
|
|
|
|
|
|
||
Sales and marketing |
|
|
|
|
|
|
||
Research and development |
|
|
|
|
|
|
||
General and administrative |
|
|
|
|
|
|
||
Total operating expenses |
|
|
|
|
|
|
||
Loss from operations |
|
|
( |
) |
|
|
( |
) |
Other expense, net |
|
|
( |
) |
|
|
( |
) |
Loss before provision for income taxes |
|
|
( |
) |
|
|
( |
) |
Provision for income taxes |
|
|
|
|
|
|
||
Net loss |
|
$ |
( |
) |
|
$ |
( |
) |
Net loss per share attributable to Class A common stockholders |
|
$ |
( |
) |
|
$ |
( |
) |
Weighted average shares used in computing net loss |
|
|
|
|
|
|
See the accompanying notes to condensed consolidated financial statements.
8
NUTANIX, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(Unaudited)
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands) |
|
|||||
Net loss |
|
$ |
( |
) |
|
$ |
( |
) |
Other comprehensive income (loss), net of tax: |
|
|
|
|
|
|
||
Change in unrealized loss on available-for-sale |
|
|
( |
) |
|
|
|
|
Comprehensive loss |
|
$ |
( |
) |
|
$ |
( |
) |
See the accompanying notes to condensed consolidated financial statements.
9
NUTANIX, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT
(Unaudited)
|
|
Three Months Ended October 31, 2022 |
|
|||||||||||||||||||||
|
|
Common Stock |
|
|
Additional |
|
|
Accumulated |
|
|
Accumulated |
|
|
Total |
|
|||||||||
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Loss |
|
|
Deficit |
|
|
Deficit |
|
||||||
|
|
(in thousands) |
|
|||||||||||||||||||||
Balance - July 31, 2022 |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|||
Issuance of common stock through employee equity |
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|||
Issuance of common stock from ESPP purchase |
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|||
Stock-based compensation |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Other comprehensive loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Net loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Balance - October 31, 2022 |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
|
Three Months Ended October 31, 2023 |
|
|||||||||||||||||||||
|
|
Common Stock |
|
|
Additional |
|
|
Accumulated |
|
|
Accumulated |
|
|
Total |
|
|||||||||
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Loss |
|
|
Deficit |
|
|
Deficit |
|
||||||
|
|
(in thousands) |
|
|||||||||||||||||||||
Balance - July 31, 2023 |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|||
Issuance of common stock through employee equity |
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|||
Issuance of common stock from ESPP purchase |
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|||
Repurchase and retirement of common stock |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Stock-based compensation |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Other comprehensive income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
Net loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Balance - October 31, 2023 |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
See the accompanying notes to condensed consolidated financial statements.
10
NUTANIX, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands) |
|
|||||
Cash flows from operating activities: |
|
|
|
|
|
|
||
Net loss |
|
$ |
( |
) |
|
$ |
( |
) |
Adjustments to reconcile net loss to net cash provided by operating activities: |
|
|
|
|
|
|
||
Depreciation and amortization |
|
|
|
|
|
|
||
Stock-based compensation |
|
|
|
|
|
|
||
Amortization of debt discount and issuance costs |
|
|
|
|
|
|
||
Operating lease cost, net of accretion |
|
|
|
|
|
|
||
Early exit of lease-related assets |
|
|
( |
) |
|
|
|
|
Non-cash interest expense |
|
|
|
|
|
|
||
Other |
|
|
( |
) |
|
|
( |
) |
Changes in operating assets and liabilities: |
|
|
|
|
|
|
||
Accounts receivable, net |
|
|
|
|
|
|
||
Deferred commissions |
|
|
|
|
|
|
||
Prepaid expenses and other assets |
|
|
|
|
|
|
||
Accounts payable |
|
|
( |
) |
|
|
|
|
Accrued compensation and benefits |
|
|
( |
) |
|
|
( |
) |
Accrued expenses and other liabilities |
|
|
( |
) |
|
|
( |
) |
Operating leases, net |
|
|
( |
) |
|
|
( |
) |
Deferred revenue |
|
|
|
|
|
|
||
Net cash provided by operating activities |
|
|
|
|
|
|
||
Cash flows from investing activities: |
|
|
|
|
|
|
||
Maturities of investments |
|
|
|
|
|
|
||
Purchases of investments |
|
|
( |
) |
|
|
( |
) |
Purchases of property and equipment |
|
|
( |
) |
|
|
( |
) |
Net cash used in investing activities |
|
|
( |
) |
|
|
( |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
||
Proceeds from sales of shares through employee equity incentive plans |
|
|
|
|
|
|
||
Repurchases of common stock |
|
|
|
|
|
( |
) |
|
Payment of finance lease obligations |
|
|
( |
) |
|
|
( |
) |
Net cash provided by (used in) financing activities |
|
|
|
|
|
( |
) |
|
Net increase in cash, cash equivalents and restricted cash |
|
$ |
|
|
$ |
|
||
Cash, cash equivalents and restricted cash—beginning of period |
|
|
|
|
|
|
||
Cash, cash equivalents and restricted cash—end of period |
|
$ |
|
|
$ |
|
||
Restricted cash (1) |
|
|
|
|
|
|
||
Cash and cash equivalents—end of period |
|
$ |
|
|
$ |
|
||
Supplemental disclosures of cash flow information: |
|
|
|
|
|
|
||
Cash paid for income taxes |
|
$ |
|
|
$ |
|
||
Supplemental disclosures of non-cash investing and |
|
|
|
|
|
|
||
Purchases of property and equipment included in accounts payable |
|
$ |
|
|
$ |
|
||
Finance lease liabilities arising from obtaining right-of-use assets |
|
$ |
|
|
$ |
|
See the accompanying notes to condensed consolidated financial statements.
11
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 1. OVERVIEW AND BASIS OF PRESENTATION
Organization and Description of Business
Nutanix, Inc. was incorporated in the state of Delaware in September 2009. Nutanix, Inc. is headquartered in San Jose, California, and together with its wholly-owned subsidiaries (collectively, "we," "us," "our" or "Nutanix"), has operations throughout North America, Europe, Asia Pacific, the Middle East, Latin America, and Africa.
We provide a leading enterprise cloud platform, which we call the Nutanix Cloud Platform, that consists of software solutions and cloud services that power our customers’ enterprise infrastructure. Our solutions deliver a consistent cloud operating model across edge, private-, hybrid- and multicloud environments for all applications and their data. Our solutions allow organizations to simply run and move their workloads, including enterprise applications, high-performance databases, end-user computing and virtual desktop infrastructure services, container-based modern applications, and analytics applications, between on-premises and public clouds. Our solutions are primarily sold through channel partners and original equipment manufacturers ("OEMs") (collectively, "Partners"), and delivered directly to our end customers.
Principles of Consolidation and Significant Accounting Policies
The accompanying condensed consolidated financial statements, which include the accounts of Nutanix, Inc. and its wholly-owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP") and are consistent in all material respects with those included in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023, filed with the Securities and Exchange Commission ("SEC") on September 21, 2023. All intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements are unaudited, but include all adjustments of a normal recurring nature necessary for a fair presentation of our quarterly results. The consolidated balance sheet as of July 31, 2023 is derived from audited financial statements; however, it does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023.
Use of Estimates
The preparation of interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such management estimates and assumptions include, but are not limited to, the best estimate of selling prices for products and related support; useful lives and recoverability of intangible assets and property and equipment; allowance for credit losses; determination of fair value of stock-based awards; accounting for income taxes, including the valuation allowance on deferred tax assets and uncertain tax positions; purchase commitment liabilities to our contract manufacturers; sales commissions expense and the period of benefit for deferred commissions; whether an arrangement is or contains a lease; the incremental borrowing rate to measure the present value of right-of-use assets and lease liabilities; the inputs used to determine the fair value of the contingent liability associated with the conversion feature of the
12
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Concentration of Risk
Concentration of revenue and accounts receivable—We sell our products primarily through our Partners and occasionally directly to end customers. For the three months ended October 31, 2022 and 2023, no end customer accounted for more than
For each significant Partner, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows:
|
|
Revenue |
|
|
Accounts Receivable as of |
|
||||||||||
|
|
Three Months Ended |
|
|
July 31, |
|
|
October 31, |
|
|||||||
Partners |
|
2022 |
|
|
2023 |
|
|
|
|
|
|
|
||||
Partner A |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
||||
Partner B |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
||||
Partner C |
|
(1) |
|
|
(1) |
|
|
|
% |
|
|
% |
||||
Partner D |
|
|
% |
|
|
% |
|
(1) |
|
|
(1) |
|
Summary of Significant Accounting Policies
There have been no changes to our significant accounting policies described in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023, filed with the SEC on September 21, 2023, that have had a material impact on our condensed consolidated financial statements.
Recent Accounting Pronouncements
We have implemented all applicable accounting pronouncements that are in effect and there are no new accounting pronouncements that have been issued that would have a material impact on our condensed consolidated financial statements.
NOTE 2. CORRECTION TO PRIOR PERIOD FINANCIAL STATEMENTS
In connection with the completed Audit Committee investigation, as initially disclosed in our Annual Report on Form 10-K/A filed with the SEC on May 24, 2023, and subsequent to the issuance of the condensed consolidated financial statements for the fiscal quarter ended October 31, 2022, we discovered an error in the reporting of expenses for software licenses and support for each prior period beginning in August 2014, resulting in an immaterial understatement of operating expenses and accrued expenses and other current liabilities for these prior periods. We have evaluated the materiality of this error and determined that the impact is not material to our previously issued financial statements. We have determined to prospectively correct our previously issued financial statements to reflect the correction of this error rather than record a cumulative out-of-period adjustment for this error in the current period. As a result, we have corrected the accompanying condensed consolidated financial statements as of and for the three months ended October 31, 2022, from amounts previously reported to reflect the correction of this error. The correction reflects our estimates of future payments for past non-compliant use of third-party software. Actual amounts may vary materially from these estimates.
13
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
The following tables summarize the effects of the correction:
|
|
Three Months Ended October 31, 2022 |
|
|||||||||
|
|
As Previously Reported |
|
|
Adjustments |
|
|
As Corrected |
|
|||
|
|
(in thousands) |
|
|||||||||
Condensed Consolidated Statement of Operations: |
|
|
|
|
|
|
|
|
|
|||
Sales and marketing |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Research and development |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Total operating expenses |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Loss from operations |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Loss before provision for income taxes |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Net loss |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Net loss per share attributable to common |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
|
Three Months Ended October 31, 2022 |
|
|||||||||
|
|
As Previously Reported |
|
|
Adjustments |
|
|
As Corrected |
|
|||
|
|
(in thousands) |
|
|||||||||
Condensed Consolidated Statement of Comprehensive Loss: |
|
|
|
|
|
|
|
|||||
Net loss |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Comprehensive loss |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
|
As Previously Reported |
|
|
Adjustments |
|
|
As Corrected |
|
|||
|
|
(in thousands) |
|
|||||||||
Condensed Consolidated Statement of Stockholders' Deficit: |
|
|
|
|
|
|
|
|||||
Accumulated Deficit as of: |
|
|
|
|
|
|
|
|
|
|||
October 31, 2022 |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
|
|
|
|
|
|
|
|
|
|||
Total Stockholders' Deficit as of: |
|
|
|
|
|
|
|
|
|
|||
October 31, 2022 |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
|
|
|
|
|
|
|
|
|
|||
Net Loss for the Three Months Ended: |
|
|
|
|
|
|
|
|
|
|||
October 31, 2022 |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
|
Three Months Ended October 31, 2022 |
|
|||||||||
|
|
As Previously Reported |
|
|
Adjustments |
|
|
As Corrected |
|
|||
|
|
(in thousands) |
|
|||||||||
Condensed Consolidated Statement of Cash Flows: |
|
|
|
|
|
|
|
|||||
Net loss |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Accrued expenses and other liabilities |
|
$ |
( |
) |
|
$ |
|
|
$ |
( |
) |
14
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
NOTE 3. REVENUE, DEFERRED REVENUE AND DEFERRED COMMISSIONS
Disaggregation of Revenue and Revenue Recognition
We generate revenue primarily from the sale of our enterprise cloud platform, which can be delivered pre-installed on an appliance that is configured to order or delivered separately to be utilized on a variety of certified hardware platforms. When the software license is not portable to other appliances, it can be used over the life of the associated appliance, while subscription term-based licenses typically have a term of to
The following table depicts the disaggregation of revenue by revenue type, consistent with how we evaluate our financial performance:
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands) |
|
|||||
Subscription |
|
$ |
|
|
$ |
|
||
Professional services |
|
|
|
|
|
|
||
Other non-subscription product (1) |
|
|
|
|
|
|
||
Total revenue |
|
$ |
|
|
$ |
|
Subscription revenue — Subscription revenue includes any performance obligation which has a defined term and is generated from the sales of software entitlement and support subscriptions, subscription software licenses and cloud-based software as a service ("SaaS") offerings.
Professional services revenue — We also sell professional services with our products. We recognize revenue related to professional services as they are performed.
Other non-subscription product revenue — Other non-subscription product revenue includes $
15
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Contracts with multiple performance obligations — The majority of our contracts with customers contain multiple performance obligations. For these contracts, we account for individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price ("SSP") basis. For deliverables that we routinely sell separately, such as software entitlement and support subscriptions on our core offerings, we determine SSP by evaluating the standalone sales over the trailing 12 months. For those that are not sold routinely, we determine SSP based on our overall pricing trends and objectives, taking into consideration market conditions and other factors, including the value of our contracts, the products sold and geographic locations.
Contract balances — The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. A receivable is recognized in the period in which we deliver goods or provide services, or when our right to consideration is unconditional. In situations where revenue recognition occurs before invoicing, an unbilled receivable is created, which represents a contract asset. The balance of unbilled accounts receivable, included in accounts receivable, net on the condensed consolidated balance sheets, was $
Payment terms on invoiced amounts are typically 30-45 days. We assess credit losses on accounts receivable by taking into consideration past collection experience, the credit quality of the customer, the age of the receivable balance, current and future economic conditions, and forecasts that may affect the collectability of the reported amount. The balance of accounts receivable, net of allowance for credit losses, as of July 31, 2023 and October 31, 2023 is presented in the accompanying condensed consolidated balance sheets.
Costs to obtain and fulfill a contract — We capitalize commissions paid to sales personnel and the related payroll taxes when customer contracts are signed. These costs are recorded as deferred commissions in the condensed consolidated balance sheets, current and non-current. We determine whether costs should be deferred based on our sales compensation plans, if the commissions are incremental and would not have been incurred absent the execution of the customer contract. Commissions paid upon the initial acquisition of a contract are recognized over the estimated period of benefit, which may exceed the term of the initial contract if the commissions expected to be paid upon renewal are not commensurate with that of the initial contract. Accordingly, deferred costs are recognized on a systematic basis that is consistent with the pattern of revenue recognition allocated to each performance obligation over the entire period of benefit and included in sales and marketing expense in the condensed consolidated statements of operations. We determine the estimated period of benefit by evaluating the expected renewals of customer contracts, the duration of relationships with our customers, customer retention data, our technology development lifecycle and other factors. Deferred costs are periodically reviewed for impairment.
Taxes assessed by a government authority that are both imposed on and concurrent with specific revenue transactions between us and our customers are presented on a net basis in our condensed consolidated statements of operations.
Deferred revenue — Deferred revenue primarily consists of amounts that have been invoiced but not yet recognized as revenue and primarily pertain to software entitlement and support subscriptions and professional services. The current portion of deferred revenue represents the amounts that are expected to be recognized as revenue within one year of the condensed consolidated balance sheet date.
16
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Significant changes in the balance of deferred revenue (contract liability) and deferred commissions (contract asset) for the periods presented are as follows:
|
|
Deferred |
|
|
Deferred |
|
||
|
|
(in thousands) |
|
|||||
Balance as of July 31, 2023 |
|
$ |
|
|
$ |
|
||
Additions (1) |
|
|
|
|
|
|
||
Revenue/commissions recognized |
|
|
( |
) |
|
|
( |
) |
Balance as of October 31, 2023 |
|
$ |
|
|
$ |
|
During the three months ended October 31, 2022, we recognized revenue of approximately $
Many of our contracted but not invoiced performance obligations are subject to cancellation terms. Revenue allocated to remaining performance obligations represents contracted revenue that has not yet been recognized ("contracted not recognized"), which includes deferred revenue and non-cancelable amounts that will be invoiced and recognized as revenue in future periods and excludes performance obligations that are subject to cancellation terms. Contracted not recognized revenue was approximately $
NOTE 4. FAIR VALUE MEASUREMENTS
The fair value of our financial assets measured on a recurring basis is as follows:
|
|
As of July 31, 2023 |
|
|||||||||||||
|
|
Level I |
|
|
Level II |
|
|
Level III |
|
|
Total |
|
||||
|
|
(in thousands) |
|
|||||||||||||
Financial Assets, Current: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Money market funds |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
U.S. Government securities |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Commercial paper |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Short-term investments: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Corporate bonds |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Commercial paper |
|
|
|
|
|
|
|
|
|
|
|
|
||||
U.S. Government securities |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total measured at fair value |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Cash |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total cash, cash equivalents and short-term investments |
|
|
|
|
|
|
|
|
|
|
$ |
|
||||
Financial Assets, Non-Current: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Convertible note receivable |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
17
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
|
|
As of October 31, 2023 |
|
|||||||||||||
|
|
Level I |
|
|
Level II |
|
|
Level III |
|
|
Total |
|
||||
|
|
(in thousands) |
|
|||||||||||||
Financial Assets, Current: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Money market funds |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
U.S. Government securities |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Commercial paper |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Short-term investments: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Corporate bonds |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Commercial paper |
|
|
|
|
|
|
|
|
|
|
|
|
||||
U.S. Government securities |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total measured at fair value |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Cash |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total cash, cash equivalents and short-term investments |
|
|
|
|
|
|
|
|
|
|
$ |
|
||||
Financial Assets, Non-Current: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Convertible note receivable |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
Financial Instruments Not Recorded at Fair Value on a Recurring Basis
We report our financial instruments at fair value, with the exception of the 2026 Notes and the
|
|
As of July 31, 2023 |
|
|
As of October 31, 2023 |
|
||||||||||
|
|
Carrying |
|
|
Estimated |
|
|
Carrying |
|
|
Estimated |
|
||||
|
|
(in thousands) |
|
|||||||||||||
2026 Notes |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
2027 Notes |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
The carrying value of the 2026 Notes as of July 31, 2023 and October 31, 2023 included $
The carrying value of the 2027 Notes as of July 31, 2023 and October 31, 2023 was net of unamortized debt issuance costs of $
The total estimated fair value of the 2026 Notes is based on a binomial model. We consider the fair value of the 2026 Notes to be a Level III valuation, as the 2026 Notes are not publicly traded. The Level III inputs used to determine the estimated fair value of the 2026 Notes include the conversion rate, risk-free interest rate, discount rate, volatility, and the price of our Class A common stock.
The total estimated fair value of the 2027 Notes was determined based on the closing trading price per $
18
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
NOTE 5. BALANCE SHEET COMPONENTS
Short-Term Investments
The amortized cost of our short-term investments approximates their fair value. Unrealized losses related to our short-term investments are generally due to interest rate fluctuations, as opposed to credit quality. However, we review individual securities that are in an unrealized loss position in order to evaluate whether or not they have experienced or are expected to experience credit losses that would result in a decline in fair value. As of July 31, 2023 and October 31, 2023, unrealized gains and losses from our short-term investments were not material and were not the result of a decline in credit quality. As a result, as of July 31, 2023 and October 31, 2023, we did not record any credit losses for these investments.
The following table summarizes the estimated fair value of our investments in marketable debt securities by their contractual maturity dates:
|
|
As of |
|
|
|
|
(in thousands) |
|
|
Due within one year |
|
$ |
|
|
Due in one to two years |
|
|
|
|
Total |
|
$ |
|
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consists of the following:
|
|
As of |
|
|||||
|
|
July 31, |
|
|
October 31, |
|
||
|
|
(in thousands) |
|
|||||
Prepaid operating expenses |
|
$ |
|
|
$ |
|
||
VAT receivables |
|
|
|
|
|
|
||
Other current assets |
|
|
|
|
|
|
||
Total prepaid expenses and other current assets |
|
$ |
|
|
$ |
|
The decrease in prepaid expenses and other current assets from July 31, 2023 to October 31, 2023 was due primarily to the release of the insurance receivable and settlement payment made to escrow related to the securities class action lawsuit, as the settlement was paid out during the fiscal quarter ended October 31, 2023. For additional details on legal proceedings, refer to Note 8.
19
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Property and Equipment, Net
Property and equipment, net consists of the following:
|
|
|
|
As of |
|
|||||
|
|
Estimated |
|
July 31, |
|
|
October 31, |
|
||
|
|
(in months) |
|
(in thousands) |
|
|||||
Computer, production, engineering and other equipment |
|
|
$ |
|
|
$ |
|
|||
Demonstration units |
|
|
|
|
|
|
|
|||
Leasehold improvements |
|
(1) |
|
|
|
|
|
|
||
Furniture and fixtures |
|
|
|
|
|
|
|
|||
Total property and equipment, gross |
|
|
|
|
|
|
|
|
||
Less: accumulated depreciation |
|
|
|
|
( |
) |
|
|
( |
) |
Total property and equipment, net |
|
|
|
$ |
|
|
$ |
|
Depreciation expense related to our property and equipment was $
Goodwill and Intangible Assets, Net
There was no change in the carrying value of goodwill during the three months ended October 31, 2023.
Intangible assets, net consists of the following:
|
|
As of |
|
|||||
|
|
July 31, |
|
|
October 31, |
|
||
|
|
(in thousands) |
|
|||||
Developed technology |
|
$ |
|
|
$ |
|
||
Customer relationships |
|
|
|
|
|
|
||
Trade name |
|
|
|
|
|
|
||
Total intangible assets, gross |
|
|
|
|
|
|
||
Less: |
|
|
|
|
|
|
||
Accumulated amortization of developed technology |
|
|
( |
) |
|
|
( |
) |
Accumulated amortization of customer relationships |
|
|
( |
) |
|
|
( |
) |
Accumulated amortization of trade name |
|
|
( |
) |
|
|
( |
) |
Total accumulated amortization |
|
|
( |
) |
|
|
( |
) |
Total intangible assets, net |
|
$ |
|
|
$ |
|
Amortization expense related to our intangible assets is recognized in the condensed consolidated statements of operations within product cost of revenue for developed technology and sales and marketing expense for customer relationships and trade name.
The estimated future amortization expense of our intangible assets is as follows:
Fiscal Year Ending July 31: |
|
Amount |
|
|
|
|
(in thousands) |
|
|
2024 (remaining nine months) |
|
$ |
|
|
2025 |
|
|
|
|
Total |
|
$ |
|
20
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Accrued Compensation and Benefits
Accrued compensation and benefits consists of the following:
|
|
As of |
|
|||||
|
|
July 31, |
|
|
October 31, |
|
||
|
|
(in thousands) |
|
|||||
Accrued commissions |
|
$ |
|
|
$ |
|
||
Accrued vacation |
|
|
|
|
|
|
||
Accrued wages and taxes |
|
|
|
|
|
|
||
Payroll taxes payable |
|
|
|
|
|
|
||
Accrued benefits |
|
|
|
|
|
|
||
Contributions to ESPP withheld |
|
|
|
|
|
|
||
Accrued bonus |
|
|
|
|
|
|
||
Other |
|
|
|
|
|
|
||
Total accrued compensation and benefits |
|
$ |
|
|
$ |
|
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consists of the following:
|
|
As of |
|
|||||
|
|
July 31, |
|
|
October 31, |
|
||
|
|
(in thousands) |
|
|||||
Accrued professional services |
|
$ |
|
|
$ |
|
||
Software usage liability |
|
|
|
|
|
|
||
Litigation settlement reserves |
|
|
|
|
|
|
||
Income taxes payable |
|
|
|
|
|
|
||
Other |
|
|
|
|
|
|
||
Total accrued expenses and other current liabilities |
|
$ |
|
|
$ |
|
The decrease in accrued expenses and other current liabilities from July 31, 2023 to October 31, 2023 was due primarily to the release of the litigation settlement reserve related to the securities class action lawsuit, that was settled and paid out during the fiscal quarter ended October 31, 2023. For additional details on legal proceedings, refer to Note 8.
NOTE 6. CONVERTIBLE SENIOR NOTES
2023 Notes
In January 2018, we issued the 2023 Notes with a
On September 22, 2021, we consummated privately negotiated exchanges with certain holders of the outstanding 2023 Notes, pursuant to which such holders exchanged approximately $
In January 2023, we settled the 2023 Notes in full at maturity with a cash payment of $
21
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
The following table sets forth the total interest expense recognized related to the 2023 Notes:
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands) |
|
|||||
Interest expense related to amortization of debt issuance costs |
|
$ |
|
|
$ |
|
Note Hedges and Warrants
Concurrently with the offering of the 2023 Notes in January 2018, we entered into convertible note hedge transactions with certain bank counterparties, whereby we have the initial option to purchase a total of approximately
In September 2021, in connection with the exchange and repurchase transactions described above, we terminated portions of the convertible note hedge transactions and warrant transactions previously entered into with certain financial institutions in connection with the issuance of the 2023 Notes. The net effect of these unwind transactions was a $
In January 2023, the convertible note hedges and warrant transactions expired concurrently with the expiration of the 2023 Notes. No settlement is required as the stock has remained below the strike price throughout the unwind settlement averaging period.
2026 Notes
In September 2020, we issued $
The 2026 Notes bear interest at a rate of
22
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
The 2026 Notes are convertible at an initial conversion rate of
On or after September 15, 2025, the 2026 Notes will be redeemable by us, at our option, in the event that the closing sale price of our Class A common stock has been at least
Holders who convert their 2026 Notes in connection with certain corporate events that constitute a "make-whole fundamental change" (as defined in the indenture governing the 2026 Notes) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, if we undergo a "fundamental change" (as defined in the indenture governing the 2026 Notes) prior to the maturity date, holders of the 2026 Notes may require us to repurchase for cash all or a portion of their 2026 Notes at a repurchase price equal to
In accordance with accounting guidance on embedded conversion features, we valued and bifurcated the conversion option associated with the 2026 Notes from the respective host debt instrument, which is treated as a debt discount, and initially recorded the conversion option of $
The 2026 Notes consisted of the following:
|
|
As of |
|
|||||
|
|
July 31, |
|
|
October 31, |
|
||
|
|
(in thousands) |
|
|||||
Principal amounts: |
|
|
|
|
|
|
||
Principal |
|
$ |
|
|
$ |
|
||
Non-cash interest expense converted to principal |
|
|
|
|
|
|
||
Unamortized debt discount (conversion feature) (1) |
|
|
( |
) |
|
|
( |
) |
Unamortized debt issuance costs (1) |
|
|
( |
) |
|
|
( |
) |
Net carrying amount |
|
$ |
|
|
$ |
|
As of October 31, 2023, the remaining life of the 2026 Notes was approximately
23
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
The following table sets forth the total interest expense recognized related to the 2026 Notes:
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands) |
|
|||||
Interest expense related to amortization of debt discount |
|
$ |
|
|
$ |
|
||
Interest expense related to amortization of debt issuance costs |
|
|
|
|
|
|
||
Non-cash interest expense |
|
|
|
|
|
|
||
Total interest expense |
|
$ |
|
|
$ |
|
Non-cash interest expense is related to the
Upon the conversion price of the 2026 Notes becoming fixed, subject to customary anti-dilution and other adjustments, in September 2021, the embedded conversion option for the 2026 Notes no longer required bifurcation because the conversion features are now considered indexed to our own equity and meet the equity classification conditions. The carrying amount of the derivative liability of $
2027 Notes
In September 2021, we issued $
The 2027 Notes bear interest at a rate of
The 2027 Notes are convertible into cash, shares of our Class A common stock, or a combination of cash and shares of Class A common stock, at our election. Each $
24
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Upon conversion of the 2027 Notes, we will pay or deliver, as the case may be, cash, shares of our Class A common stock or a combination of cash and shares of Class A common stock, at our election. We intend to settle the principal of the 2027 Notes in cash.
The conversion rate will be subject to adjustment in certain events, but will not be adjusted for any accrued or unpaid interest. Holders who convert their 2027 Notes in connection with certain corporate events that constitute a "make-whole fundamental change" (as defined in the indenture governing the 2027 Notes) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, if we undergo a "fundamental change" (as defined in the indenture governing the 2027 Notes) prior to the maturity date, holders of the 2027 Notes may require us to repurchase for cash all or a portion of their 2027 Notes at a repurchase price equal to
In accounting for the exchange of convertible notes, we evaluated whether the transaction should be treated as a modification or extinguishment transaction. The partial exchange of the 2023 Notes and issuance of the 2027 Notes were deemed to have substantially different terms due to the significant difference between the value of the conversion option immediately prior to and after the exchange, and consequently, the 2023 Notes partial exchange was accounted for as a debt extinguishment. The $
The 2027 Notes consisted of the following:
|
|
As of |
|
|||||
|
|
July 31, |
|
|
October 31, |
|
||
|
|
(in thousands) |
|
|||||
Principal amounts: |
|
|
|
|
|
|
||
Principal |
|
$ |
|
|
$ |
|
||
Unamortized debt issuance costs (1) |
|
|
( |
) |
|
|
( |
) |
Net carrying amount |
|
$ |
|
|
$ |
|
As of October 31, 2023, the remaining life of the 2027 Notes was approximately
The following table sets forth the total interest expense recognized related to the 2027 Notes:
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands) |
|
|||||
Contractual interest expense |
|
$ |
|
|
$ |
|
||
Interest expense related to amortization of debt issuance costs |
|
|
|
|
|
|
||
Total interest expense |
|
$ |
|
|
$ |
|
NOTE 7. LEASES
We have operating leases for offices, research and development facilities and datacenters and finance leases for certain datacenter equipment. Our leases have remaining lease terms of
25
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Total operating lease cost was $
During the three months ended October 31, 2022, we signed agreements to early exit certain office spaces in the United States. The reduction in the lease term resulted in a decrease to the carrying amount of the operating lease liability and the operating lease right-of-use asset on our condensed consolidated balance sheet as of October 31, 2022. In addition, we recorded $
Supplemental balance sheet information related to leases is as follows:
|
|
As of |
|
|||||
|
|
July 31, |
|
|
October 31, |
|
||
|
|
(in thousands) |
|
|||||
Operating leases: |
|
|
|
|
|
|
||
Operating lease right-of-use assets, gross |
|
$ |
|
|
$ |
|
||
Accumulated amortization |
|
|
( |
) |
|
|
( |
) |
Operating lease right-of-use assets, net |
|
$ |
|
|
$ |
|
||
Operating lease liabilities—current |
|
$ |
|
|
$ |
|
||
Operating lease liabilities—non-current |
|
|
|
|
|
|
||
Total operating lease liabilities |
|
$ |
|
|
$ |
|
||
Weighted average remaining lease term (in years): |
|
|
|
|
|
|
||
Weighted average discount rate: |
|
|
% |
|
|
% |
26
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
|
|
As of |
|
|||||
|
|
July 31, |
|
|
October 31, |
|
||
|
|
(in thousands) |
|
|||||
Finance leases: |
|
|
|
|
|
|
||
Finance lease right-of-use assets, gross (1) |
|
$ |
|
|
$ |
|
||
Accumulated amortization (1) |
|
|
( |
) |
|
|
( |
) |
, net (1) |
|
$ |
|
|
$ |
|
||
(2) |
|
$ |
|
|
$ |
|
||
(3) |
|
|
|
|
|
|
||
|
$ |
|
|
$ |
|
|||
Weighted average remaining lease term (in years): |
|
|
|
|
|
|
||
Weighted average discount rate: |
|
|
% |
|
|
% |
Supplemental cash flow and other information related to leases is as follows:
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands) |
|
|||||
Cash paid for amounts included in the measurement of |
|
|
|
|
|
|
||
Operating cash flows from operating leases |
|
$ |
|
|
$ |
|
||
Financing cash flows from finance leases |
|
$ |
|
|
$ |
|
||
Lease liabilities arising from obtaining right-of-use assets: |
|
|
|
|
|
|
||
Operating leases |
|
$ |
|
|
$ |
|
The undiscounted cash flows for our operating lease liabilities as of October 31, 2023 were as follows:
Fiscal Year Ending July 31: |
|
Operating |
|
|
Finance |
|
|
Total |
|
|||
|
|
(in thousands) |
|
|||||||||
2024 (remaining nine months) |
|
$ |
|
|
$ |
|
|
$ |
|
|||
2025 |
|
|
|
|
|
|
|
|
|
|||
2026 |
|
|
|
|
|
|
|
|
|
|||
2027 |
|
|
|
|
|
|
|
|
|
|||
2028 |
|
|
|
|
|
|
|
|
|
|||
Thereafter |
|
|
|
|
|
|
|
|
|
|||
Total lease payments |
|
|
|
|
|
|
|
|
|
|||
Less: imputed interest |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Total lease obligation |
|
|
|
|
|
|
|
|
|
|||
Less: current lease obligations |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Long-term lease obligations |
|
$ |
|
|
$ |
|
|
$ |
|
As of October 31, 2023, we did not have any additional operating lease commitments for office leases that have not yet commenced.
27
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
NOTE 8. COMMITMENTS AND CONTINGENCIES
Purchase Commitments
In the normal course of business, we make commitments with our contract manufacturers to ensure them a minimum level of financial consideration for their investment in our joint solutions. These commitments are based on performance targets or on-hand inventory and non-cancelable purchase orders for non-standard components. We record a charge related to these items when we determine that it is probable a loss will be incurred and we are able to estimate the amount of the loss. Our historical charges have not been material. As of October 31, 2023, we had up to approximately $
Legal Proceedings
Securities Class Actions. Beginning on March 29, 2019, several purported securities class actions were filed in the United States District Court for the Northern District of California against us and two of our officers. The initial complaints generally alleged that the defendants made false and misleading statements in violation of Sections 10(b) and 20(a) of the Exchange Act and SEC Rule 10b-5. In July 2019, the court consolidated the actions into a single action, and appointed a lead plaintiff, who then filed a consolidated amended complaint (the "Original Complaint"). The action was brought on behalf of those who purchased or otherwise acquired our stock between November 30, 2017 and May 30, 2019, inclusive. The defendants subsequently filed a motion to dismiss the Original Complaint, which the court granted on March 9, 2020, while providing the lead plaintiff leave to amend. On April 17, 2020, the lead plaintiff filed a second amended complaint (the "Amended Complaint"), again naming us and two of our officers as defendants. The Amended Complaint alleges the same class period, includes many of the same factual allegations as the Original Complaint, and again alleges that the defendants violated Sections 10(b) and 20(a) of the Exchange Act, as well as SEC Rule 10b-5. The Amended Complaint sought monetary damages in an unspecified amount. On September 11, 2020, the court denied the defendants' motion to dismiss the Amended Complaint and held that the lead plaintiff adequately stated a claim with respect to certain statements regarding our new customer growth and sales productivity. On January 27, 2021, lead plaintiff, Shimon Hedvat, filed a motion to (i) withdraw as lead plaintiff and (ii) substitute proposed new lead plaintiffs and approve their appointment of a new co-lead counsel. On March 1, 2021, the court granted the lead plaintiff’s motion to withdraw as lead plaintiff but denied without prejudice his motion to substitute proposed new lead plaintiffs. The court also reopened the lead plaintiff selection process, allowing any putative class member interested in serving as the new lead plaintiff to file a lead plaintiff application. Following the lead plaintiff selection hearing on April 28, 2021, on June 10, 2021 the court appointed California Ironworkers Field Pension Trust as lead plaintiff and approved its appointment of counsel. On May 28, 2021, one of the movants for lead plaintiff, John P. Norton on behalf of the Norton Family Living Trust UAD 11/15/2002, filed a separate class action complaint (the "Options Class Action Complaint") in the Northern District of California on behalf of a class of persons or entities who transacted in publicly traded call options and/or put options on Nutanix stock during the period from November 30, 2017 and May 30, 2019, containing allegations substantively the same as those alleged in the Amended Complaint (the "Options Class Action") and naming the same defendants. On September 8, 2021, the court appointed the John P. Norton on behalf of the Norton Family Living Trust UAD 11/15/2002 as the lead plaintiff in the Options Class Action. On April 26, 2022, the parties met for mediation, which did not result in a settlement. On September 1, 2022, California Ironworkers Field Pension Trust filed a third amended complaint (which amends the Amended Complaint, the "Third Amended Complaint") and John P. Norton on behalf of the Norton Family Living Trust UAD 11/15/2002 filed an amended complaint (which amends the Options Class Action Complaint, the "First Amended Complaint"). On November 14, 2022, the defendants filed a motion to dismiss the Third Amended Complaint and the First Amended Complaint. On February 9, 2023, the plaintiffs and the defendants agreed to a mediator’s recommendation to settle these actions for a total of $
28
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
On April 14, 2023, a purported federal securities class action complaint was filed in the United States District Court for the Northern District of California against us, two of our current officers, and a former officer. The complaint generally alleges that the defendants made false and misleading statements in violation of Sections 10(b) and 20(a) of the Exchange Act and SEC Rule 10b-5. The court appointed a lead plaintiff for the putative class in this action, consisting of those who purchased or otherwise acquired our securities between September 21, 2021 and March 6, 2023, inclusive. In addition, on May 5, 2023, a purported stockholder derivative complaint was filed in the United States District Court for the Northern District of California, naming our current directors as defendants and our company as a nominal defendant. The complaint generally alleges violations of Section 14(a) of the Exchange Act and breach of fiduciary duties, and aiding and abetting breach of fiduciary duties, based on similar underlying allegations contained in the purported federal securities class action complaint described above. The court has ordered that all proceedings in this stockholder derivative action be stayed pending the court's decision on any motion to dismiss in the federal securities class action. In September 2023, the Company and the lead plaintiff in the securities class action reached an agreement to dismiss the action, with prejudice as to the lead plaintiff and without prejudice as to the other members of the putative class. The settlement payment was
We are not currently a party to any other legal proceedings that we believe to be material to our business or financial condition. From time to time, we may become party to various litigation matters and subject to claims that arise in the ordinary course of business.
NOTE 9. STOCKHOLDERS’ EQUITY
We have
Holders of Class A common stock are entitled to
Share Repurchase
In August 2023, our Board of Directors authorized the repurchase of up to $
NOTE 10. EQUITY INCENTIVE PLANS
Stock Plans
We have
29
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Under the 2016 Plan, we may grant incentive stock options, non-statutory stock options, restricted stock, RSUs and stock appreciation rights to employees, directors and consultants. We initially reserved
Restricted Stock Units
Performance RSUs — We have granted RSUs that have both service and performance conditions to our executives and employees ("Performance RSUs"). Vesting of Performance RSUs is subject to continuous service and the satisfaction of certain performance targets. While we recognize cumulative stock-based compensation expense for the portion of the awards for which both the service condition has been satisfied and it is probable that the performance conditions will be met, the actual vesting and settlement of Performance RSUs are subject to the performance conditions actually being met.
Market Stock Units
In connection with his hiring, in December 2020, the Compensation Committee of our Board of Directors approved the grant of
In October 2021, August 2022, and August 2023, the Compensation Committee of our Board of Directors approved the grant of approximately
We used Monte Carlo simulations to calculate the fair value of these awards on the grant date, or modification date, as applicable. A Monte Carlo simulation requires the use of various assumptions, including the stock price volatility and risk-free interest rate as of the valuation date corresponding to the length of time remaining in the performance period and expected dividend yield. We recognize stock-based compensation expense related to these MSUs using the graded vesting attribution method over the respective performance periods. As of October 31, 2023, approximately
Below is a summary of RSU activity, including MSUs, under the Stock Plans:
|
|
Number of |
|
|
Weighted Average |
|
||
|
|
(in thousands) |
|
|
|
|
||
Outstanding at July 31, 2023 |
|
|
|
|
$ |
|
||
Granted |
|
|
|
|
$ |
|
||
Released |
|
|
( |
) |
|
$ |
|
|
Forfeited |
|
|
( |
) |
|
$ |
|
|
Outstanding at October 31, 2023 |
|
|
|
|
$ |
|
30
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Stock Options
We did
Employee Stock Purchase Plan
In December 2015, the Board adopted the 2016 Employee Stock Purchase Plan, which was subsequently amended in January 2016 and September 2016 and approved by our stockholders in March 2016 (the "Original 2016 ESPP"). The Original 2016 ESPP became effective in connection with our IPO. Our stockholders subsequently approved amendments to the Original 2016 ESPP in December 2019 and December 2022 (as amended, the "2016 ESPP"). Under the 2016 ESPP, the maximum number of shares of Class A common stock available for sale is
The 2016 ESPP allows eligible employees to purchase shares of our Class A common stock at a discount through payroll deductions of up to
On each purchase date, participating employees will purchase Class A common stock at a price per share equal to
During the three months ended October 31, 2023,
We use the Black-Scholes option pricing model to determine the fair value of shares purchased under the 2016 ESPP with the following weighted average assumptions on the date of grant:
|
|
Three Months Ended October 31, |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
Expected term (in years) |
|
|
|
|
|
|
||
Risk-free interest rate |
|
|
% |
|
|
% |
||
Volatility |
|
|
% |
|
|
% |
||
Dividend yield |
|
|
% |
|
|
% |
31
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Stock-Based Compensation
Total stock-based compensation expense recognized in the condensed consolidated statements of operations is as follows:
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands) |
|
|||||
Cost of revenue: |
|
|
|
|
|
|
||
Product |
|
$ |
|
|
$ |
|
||
Support, entitlements and other services |
|
|
|
|
|
|
||
Sales and marketing |
|
|
|
|
|
|
||
Research and development |
|
|
|
|
|
|
||
General and administrative |
|
|
|
|
|
|
||
Total stock-based compensation expense |
|
$ |
|
|
$ |
|
As of October 31, 2023, unrecognized stock-based compensation expense related to outstanding stock awards was approximately $
NOTE 11. INCOME TAXES
The income tax provisions of $
NOTE 12. RESTRUCTURING CHARGES
As of October 31, 2023, we recognized total restructuring charges of approximately $
During the three months ended October 31, 2022, we recognized restructuring charges of $
32
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Basic net income (loss) per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed by giving effect to potentially dilutive common stock equivalents outstanding during the period, as their effect would be dilutive. Potentially dilutive common shares include participating securities and shares issuable upon the exercise of stock options, the exercise of common stock warrants, the exercise of convertible preferred stock warrants, the vesting of RSUs and each purchase under the 2016 ESPP, under the if-converted method.
In loss periods, basic net loss per share and diluted net loss per share are the same, as the effect of potential common shares is antidilutive and therefore excluded.
The computation of basic and diluted net loss per share attributable to common stockholders is as follows:
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands, except per share data) |
|
|||||
Numerator: |
|
|
|
|
|
|
||
Net loss |
|
$ |
( |
) |
|
$ |
( |
) |
Denominator: |
|
|
|
|
|
|
||
Weighted average shares—basic and diluted |
|
|
|
|
|
|
||
Net loss per share attributable to common stockholders— |
|
$ |
( |
) |
|
$ |
( |
) |
The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive are as follows:
|
|
Three Months Ended October 31, |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands) |
|
|||||
Outstanding stock options and RSUs |
|
|
|
|
|
|
||
Employee stock purchase plan |
|
|
|
|
|
|
||
Common stock issuable upon the conversion of the Notes |
|
|
|
|
|
|
||
Total |
|
|
|
|
|
|
Shares that will be issued in connection with our stock awards and shares that will be purchased under the employee stock purchase plan are generally automatically converted into shares of our Class A common stock. Common stock issuable upon the conversion of convertible debt represents the antidilutive impact of the 2023 Notes, 2026 Notes and 2027 Notes under the if-converted method.
33
NUTANIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
NOTE 14. SEGMENT INFORMATION
Our chief operating decision maker is a group which is comprised of our Chief Executive Officer and Chief Financial Officer. This group reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, we have a reportable segment.
The following table sets forth revenue by geographic location based on bill-to location:
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands) |
|
|||||
U.S. |
|
$ |
|
|
$ |
|
||
Europe, the Middle East and Africa |
|
|
|
|
|
|
||
Asia Pacific |
|
|
|
|
|
|
||
Other Americas |
|
|
|
|
|
|
||
Total revenue |
|
$ |
|
|
$ |
|
The following table sets forth long-lived assets, which primarily include property and equipment, net, by geographic location:
|
|
As of |
|
|||||
|
|
July 31, |
|
|
October 31, |
|
||
|
|
(in thousands) |
|
|||||
United States |
|
$ |
|
|
$ |
|
||
International |
|
|
|
|
|
|
||
Total long-lived assets |
|
$ |
|
|
$ |
|
34
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition, results of operations and cash flows should be read in conjunction with (1) the unaudited condensed consolidated financial statements and the related notes thereto included elsewhere in this Quarterly Report on Form 10-Q and (2) the audited consolidated financial statements and notes thereto and "Management’s Discussion and Analysis of Financial Condition and Results of Operations" included in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023 filed on September 21, 2023. The last day of our fiscal year is July 31. Our fiscal quarters end on October 31, January 31, April 30 and July 31. This discussion gives effect to the correction disclosed in Note 2 of Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q, and contains forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under the heading "Risk Factors" in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended July 31, 2023 and in Part II, Item 1A of this Quarterly Report on Form 10-Q. See also "Special Note Regarding Forward-Looking Statements" above.
Overview
Nutanix, Inc. ("we," "us," "our" or "Nutanix") provides a leading enterprise cloud platform, which we call the Nutanix Cloud Platform, that consists of software solutions and cloud services that power our customers’ enterprise infrastructure. Our solutions deliver a consistent cloud operating model across edge, private-, hybrid- and multicloud environments for all applications and their data. Our solutions allow organizations to simply run and move their workloads, including enterprise applications, high-performance databases, end-user computing and virtual desktop infrastructure services, container-based modern applications, and analytics applications, between on-premises and public clouds. Our goal is to provide a single, simple, open software platform for all hybrid and multicloud applications and their data. We operate a subscription-based business model to provide our customers with the flexibility to choose the licensing that works best for them based on their specific business needs.
The Nutanix Cloud Platform can be deployed on-premises at the edge or in data centers, running on a variety of qualified hardware platforms, in popular public cloud environments such as AWS and Microsoft Azure through Nutanix Cloud Clusters, or, in the case of our cloud-based software and software-as-a-service ("SaaS") offerings, via hosted service. Our subscription term-based licenses are sold separately, or can also be sold alongside configured-to-order appliances. Our subscription term-based licenses typically have terms ranging from one to five years. Our cloud-based SaaS subscriptions have terms extending up to five years. Configured-to-order appliances, including our Nutanix-branded NX hardware line, can be purchased from one of our channel partners, original equipment manufacturers ("OEMs") or, in limited cases, directly from Nutanix.
Our enterprise cloud platform typically includes one or more years of support and entitlements, which provides customers with the right to software upgrades and enhancements as well as technical support. Purchases of term-based licenses and SaaS subscriptions have support and entitlements included within the subscription fees and are not sold separately. Purchases of non-portable software are typically accompanied by the purchase of separate support and entitlements.
Product revenue is generated primarily from the licensing of our solutions. Support, entitlements and other services revenue is primarily derived from the related support and maintenance contracts. Prior to fiscal 2019, we delivered most of our solutions on an appliance, thus our revenue included the revenue associated with the appliance and the included non-portable software, which lasts for the life of the associated appliance. However, starting in fiscal 2018, as a result of our business model transition toward software-only sales, more of our customers began buying appliances directly from our OEMs while separately buying licenses for our software solutions from us or one of our channel partners. In addition, starting in fiscal 2019, as a result of our transition toward a subscription-based business model, more of our customers began purchasing separately sold subscription term-based licenses that could be deployed on a variety of hardware platforms.
We had a broad and diverse base of over 24,000 end customers as of October 31, 2023, including approximately 1,020 Global 2000 enterprises. We define the number of end customers as the number of end customers for which we have received an order by the last day of the period, excluding partners to which we have sold products for their own demonstration purposes. A single organization or customer may represent multiple end customers for separate divisions, segments or subsidiaries, and the total number of end customers may contract due to mergers, acquisitions, or other consolidation among existing end customers.
35
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
Our solutions are primarily sold through channel partners and OEMs, and delivered directly to our end customers. Our solutions serve a broad range of workloads, including enterprise applications, databases, virtual desktop infrastructure, unified communications and big data analytics, and we support both virtualized and container-based applications. We have end customers across a broad range of industries, such as automotive, consumer goods, education, energy, financial services, healthcare, manufacturing, media, public sector, retail, technology and telecommunications. We also sell to service providers, who utilize our enterprise cloud platform to provide a variety of cloud-based services to their customers.
We continue to invest in the growth of our business over the long-run, including the development of our solutions and investing in sales and marketing to capitalize on our market opportunities, while improving our operating cash flow performance by focusing on go-to-market efficiencies. By maintaining this balance, we believe we can sustain profitable growth. As discussed further in the "Factors Affecting Our Performance" section below, as part of our overall efforts to improve our operating cash flow performance, we have proactively taken steps to manage our expenses. As a result, our overall spending on such efforts will fluctuate, and may decline, from quarter to quarter in the near-term.
As previously disclosed, in the fourth quarter of fiscal 2023, the Audit Committee of our Board of Directors completed its investigation into our management’s discovery that certain third-party evaluation software was instead used for interoperability testing, validation and customer proofs of concept over a multi-year period. In connection with the investigation, we had identified control deficiencies that, individually or in the aggregate, constitute a material weakness in our internal control over financial reporting. While our management, with the oversight of the Audit Committee, has made significant progress toward remediating this material weakness, our management determined that this material weakness has not yet been fully remediated. For more information about our remediation efforts, refer to Part I, Item 4 of this Quarterly Report on Form 10-Q. This material weakness resulted in an error in the reporting of expenses for software licenses and support for each prior period beginning in August 2014, resulting in an immaterial understatement of operating expenses and accrued expenses and other current liabilities for these prior periods. We have evaluated the materiality of this error and determined that the impact is not material to our previously issued financial statements. We have determined to prospectively correct our previously issued financial statements to reflect the correction of this error rather than record a cumulative out-of-period adjustment in the current period. As a result, we have prospectively corrected our financial statements for the affected periods to reflect the correction of this error. For more information, refer to Note 2 of Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
36
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
Key Financial and Performance Metrics
We monitor the following key financial and performance metrics:
|
|
As of and for the |
|
|||||
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands, except percentages and end customer count) |
|
|||||
Total revenue |
|
$ |
433,609 |
|
|
$ |
511,054 |
|
Year-over-year percentage increase |
|
|
14.6 |
% |
|
|
17.9 |
% |
Total billings |
|
$ |
469,730 |
|
|
$ |
561,133 |
|
Annual contract value ("ACV") billings |
|
$ |
231,928 |
|
|
$ |
287,216 |
|
Annual recurring revenue ("ARR") |
|
$ |
1,280,574 |
|
|
$ |
1,663,918 |
|
Gross profit |
|
$ |
351,114 |
|
|
$ |
429,095 |
|
Non-GAAP gross profit |
|
$ |
361,694 |
|
|
$ |
439,250 |
|
Gross margin |
|
|
81.0 |
% |
|
|
84.0 |
% |
Non-GAAP gross margin |
|
|
83.4 |
% |
|
|
85.9 |
% |
Operating expenses |
|
$ |
431,769 |
|
|
$ |
434,801 |
|
Non-GAAP operating expenses |
|
$ |
351,498 |
|
|
$ |
359,764 |
|
Operating loss |
|
$ |
(80,655 |
) |
|
$ |
(5,706 |
) |
Non-GAAP operating income |
|
$ |
10,196 |
|
|
$ |
79,486 |
|
Operating margin |
|
|
(18.6 |
)% |
|
|
(1.1 |
)% |
Non-GAAP operating margin |
|
|
2.4 |
% |
|
|
15.6 |
% |
Net cash provided by operating activities |
|
$ |
65,513 |
|
|
$ |
145,473 |
|
Free cash flow |
|
$ |
45,811 |
|
|
$ |
132,453 |
|
Total end customers (1) |
|
|
23,130 |
|
|
|
24,930 |
|
Disaggregation of Revenue and Billings
The following table depicts the disaggregation of revenue and billings by type, consistent with how we evaluate our financial performance:
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands) |
|
|||||
Disaggregation of revenue: |
|
|
|
|
|
|
||
Subscription revenue |
|
$ |
402,924 |
|
|
$ |
479,478 |
|
Professional services revenue |
|
|
22,278 |
|
|
|
22,835 |
|
Other non-subscription product revenue (1) |
|
|
8,407 |
|
|
|
8,741 |
|
Total revenue |
|
$ |
433,609 |
|
|
$ |
511,054 |
|
Disaggregation of billings: |
|
|
|
|
|
|
||
Subscription billings |
|
$ |
441,430 |
|
|
$ |
528,914 |
|
Professional services billings |
|
|
19,893 |
|
|
|
23,478 |
|
Other non-subscription product billings (1) |
|
|
8,407 |
|
|
|
8,741 |
|
Total billings |
|
$ |
469,730 |
|
|
$ |
561,133 |
|
37
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
Subscription revenue — Subscription revenue includes any performance obligation which has a defined term and is generated from the sales of software entitlement and support subscriptions, subscription software licenses and cloud-based SaaS offerings.
Professional services revenue — We also sell professional services with our products. We recognize revenue related to professional services as they are performed.
Other non-subscription product revenue — Other non-subscription product revenue includes $7.8 million and $8.1 million of non-portable software revenue for the three months ended October 31, 2022 and 2023, respectively, and $0.6 million and $0.6 million of hardware revenue for the three months ended October 31, 2022 and 2023, respectively.
Non-GAAP Financial Measures and Key Performance Measures
We regularly monitor total billings, ACV billings, ARR, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income (loss), non-GAAP operating margin, free cash flow, and total end customers, which are non-GAAP financial measures and key performance measures, to help us evaluate our growth and operational efficiencies, measure our performance, identify trends in our sales activity and establish our budgets. We evaluate these measures because they:
38
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
Total billings is a performance measure which we believe provides useful information to our management and investors, as it represents the dollar value under binding purchase orders received and billed during a given period. ACV billings is a performance measure that we believe provides useful information to our management and investors as they allow us to better track the topline growth of our subscription-based business model because it takes into account variability in term lengths. ARR is a performance measure that we believe provides useful information to our management and investors as it allows us to better track the topline growth of our subscription business because it only includes non-life-of-device contracts and takes into account variability in term lengths. Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income (loss), and non-GAAP operating margin are performance measures which we believe provide useful information to investors, as they provide meaningful supplemental information regarding our performance and liquidity by excluding certain expenses and expenditures, such as stock-based compensation expense, that may not be indicative of our ongoing core business operating results. Free cash flow is a performance measure that we believe provides useful information to management and investors about the amount of cash used in or generated by the business after necessary capital expenditures. We use these non-GAAP financial and key performance measures for financial and operational decision-making and as a means to evaluate period-to-period comparisons.
Total billings, ACV billings, ARR, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income (loss), non-GAAP operating margin, and free cash flow have limitations as analytical tools and they should not be considered in isolation or as substitutes for analysis of our results as reported under generally accepted accounting principles ("GAAP") in the United States. Total billings, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income (loss), non-GAAP operating margin, and free cash flow are not substitutes for total revenue, gross profit, gross margin, operating expenses, operating loss, operating margin, or net cash provided by (used in) operating activities, respectively. There is no GAAP measure that is comparable to ACV billings or ARR, so we have not reconciled either ACV billings or ARR numbers included in this Quarterly Report on Form 10-Q to any GAAP measure. In addition, other companies, including companies in our industry, may calculate non-GAAP financial measures and key performance measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures and key performance measures as tools for comparison. We urge you to review the reconciliation of our non-GAAP financial measures and key performance measures to the most directly comparable GAAP financial measures included below and not to rely on any single financial measure to evaluate our business.
We calculate our non-GAAP financial and key performance measures as follows:
Total billings — We calculate total billings by adding the change in deferred revenue and the change in unbilled accounts receivable between the start and end of the period to total revenue recognized in the same period.
ACV billings — We calculate ACV billings as the sum of the ACV for all contracts billed during the period. ACV is defined as the total annualized value of a contract, excluding amounts related to professional services and hardware. We calculate the total annualized value for a contract by dividing the total value of the contract by the number of years in the term of such contract, using, where applicable, an assumed term of five years for contracts that do not have a specified term.
ARR — We calculate ARR as the sum of ACV for all non-life-of-device contracts in effect as of the end of a specific period. For the purposes of this calculation, we assume that the contract term begins on the date a contract is booked, unless the terms of such contract prevent us from fulfilling our obligations until a later period, and irrespective of the periods in which we would recognize revenue for such contract.
Non-GAAP gross profit and Non-GAAP gross margin — We calculate non-GAAP gross margin as non-GAAP gross profit divided by total revenue. We define non-GAAP gross profit as gross profit adjusted to exclude stock-based compensation expense, amortization of acquired intangible assets, restructuring charges, impairment of lease-related assets, and costs associated with other non-recurring transactions. Our presentation of non-GAAP gross profit and non-GAAP gross margin should not be construed as implying that our future results will not be affected by any recurring expenses or any unusual or non-recurring items that we exclude from our calculation of these non-GAAP financial measures.
39
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
Non-GAAP operating expenses — We define non-GAAP operating expenses as total operating expenses adjusted to exclude stock-based compensation expense, amortization of acquired intangible assets, restructuring charges, impairment of lease-related assets, litigation settlement accruals and legal fees related to certain litigation matters, and costs associated with other non-recurring transactions. Our presentation of non-GAAP operating expenses should not be construed as implying that our future results will not be affected by any recurring expenses or any unusual or non-recurring items that we exclude from our calculation of this non-GAAP financial measure.
Non-GAAP operating income (loss) and Non-GAAP operating margin — We calculate non-GAAP operating margin as non-GAAP operating income (loss) divided by total revenue. We define non-GAAP operating income (loss) as operating loss adjusted to exclude stock-based compensation expense, amortization of acquired intangible assets, restructuring charges, impairment of lease-related assets, litigation settlement accruals and legal fees related to certain litigation matters, and costs associated with other non-recurring transactions. Our presentation of non-GAAP operating income (loss) and non-GAAP operating margin should not be construed as implying that our future results will not be affected by any recurring expenses or any unusual or non-recurring items that we exclude from our calculation of these non-GAAP financial measures.
Free cash flow — We calculate free cash flow as net cash provided by (used in) operating activities less purchases of property and equipment, which measures our ability to generate cash from our business operations after our capital expenditures.
Total end customers — We define the number of end customers as the number of end customers for which we have received an order by the last day of the period, excluding partners to which we have sold products for their own demonstration purposes. A single organization or customer may represent multiple end customers for separate divisions, segments, or subsidiaries, and the total number of end customers may contract due to mergers, acquisitions, or other consolidation among existing end customers.
40
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
The following table presents a reconciliation of total billings, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income (loss), non-GAAP operating margin, and free cash flow to the most directly comparable GAAP financial measures, for each of the periods indicated:
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands, except percentages) |
|
|||||
Total revenue |
|
$ |
433,609 |
|
|
$ |
511,054 |
|
Change in deferred revenue |
|
|
36,121 |
|
|
|
50,079 |
|
Total billings (non-GAAP) |
|
$ |
469,730 |
|
|
$ |
561,133 |
|
|
|
|
|
|
|
|
||
Gross profit |
|
$ |
351,114 |
|
|
$ |
429,095 |
|
Stock-based compensation |
|
|
7,505 |
|
|
|
9,044 |
|
Amortization of intangible assets |
|
|
2,810 |
|
|
|
1,111 |
|
Restructuring charges |
|
|
265 |
|
|
|
— |
|
Non-GAAP gross profit |
|
$ |
361,694 |
|
|
$ |
439,250 |
|
|
|
|
|
|
|
|
||
Gross margin |
|
|
81.0 |
% |
|
|
84.0 |
% |
Stock-based compensation |
|
|
1.7 |
% |
|
|
1.7 |
% |
Amortization of intangible assets |
|
|
0.6 |
% |
|
|
0.2 |
% |
Restructuring charges |
|
|
0.1 |
% |
|
|
— |
|
Non-GAAP gross margin |
|
|
83.4 |
% |
|
|
85.9 |
% |
|
|
|
|
|
|
|
||
Operating expenses |
|
$ |
431,769 |
|
|
$ |
434,801 |
|
Stock-based compensation |
|
|
(73,450 |
) |
|
|
(74,954 |
) |
Amortization of intangible assets |
|
|
(349 |
) |
|
|
(37 |
) |
Restructuring charges |
|
|
(5,552 |
) |
|
|
— |
|
Early exit of lease-related assets |
|
|
(920 |
) |
|
|
— |
|
Other |
|
|
— |
|
|
|
(46 |
) |
Non-GAAP operating expenses |
|
$ |
351,498 |
|
|
$ |
359,764 |
|
|
|
|
|
|
|
|
||
Loss from operations |
|
$ |
(80,655 |
) |
|
$ |
(5,706 |
) |
Stock-based compensation |
|
|
80,955 |
|
|
|
83,998 |
|
Amortization of intangible assets |
|
|
3,159 |
|
|
|
1,148 |
|
Restructuring charges |
|
|
5,817 |
|
|
|
— |
|
Early exit of lease-related assets |
|
|
920 |
|
|
|
— |
|
Other |
|
|
— |
|
|
|
46 |
|
Non-GAAP income from operations |
|
$ |
10,196 |
|
|
$ |
79,486 |
|
|
|
|
|
|
|
|
||
Operating margin |
|
|
(18.6 |
)% |
|
|
(1.1 |
)% |
Stock-based compensation |
|
|
18.8 |
% |
|
|
16.5 |
% |
Amortization of intangible assets |
|
|
0.7 |
% |
|
|
0.2 |
% |
Restructuring charges |
|
|
1.3 |
% |
|
|
— |
|
Early exit of lease-related assets |
|
|
0.2 |
% |
|
|
— |
|
Other |
|
|
— |
|
|
|
— |
|
Non-GAAP operating margin |
|
|
2.4 |
% |
|
|
15.6 |
% |
|
|
|
|
|
|
|
||
Net cash provided by operating activities |
|
$ |
65,513 |
|
|
$ |
145,473 |
|
Purchases of property and equipment |
|
|
(19,702 |
) |
|
|
(13,020 |
) |
Free cash flow (non-GAAP) |
|
$ |
45,811 |
|
|
$ |
132,453 |
|
41
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
Factors Affecting Our Performance
We believe that our future success will depend on many factors, including those described below. While these areas present significant opportunity, they also present risks that we must manage to achieve successful results. See the section titled "Risk Factors" in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended July 31, 2023 and the section titled "Risk Factors" in Part II, Item 1A of this Quarterly Report on Form 10-Q for details. If we are unable to address these challenges, our business and operating results could be materially and adversely affected.
Investment in Profitable Growth
We continue to invest in our growth over the long-run, while improving our operating cash flow performance by focusing on go-to-market efficiencies. By maintaining this balance, we believe we can sustain profitable growth.
Investment in Sales and Marketing – Our ability to achieve billings and revenue growth depends, in large part, on our ability to capitalize on our market opportunity, including our ability to recruit, train and retain sufficient numbers of ramped sales personnel to support our growth. As part of our investment in our growth over the long-run, we plan to invest in sales and marketing, including investing in our sales and marketing teams and continuing our focus on opportunities with major accounts, large deals, and commercial accounts, as well as other sales and marketing initiatives to increase our pipeline growth. As we continue to recruit additional sales representatives, it will take time to train and ramp them to full productivity. As a result, our overall sales and marketing expense may fluctuate. We estimate, based on past experience, that our average sales team members typically become fully ramped up around the start of their fourth quarter of employment with us, and as our newer employees ramp up, we expect their increased productivity to contribute to our revenue growth. As of October 31, 2023, we considered approximately 81% of our global sales team members to be fully ramped, while the remaining approximately 19% of our global sales team members are in the process of ramping up. As we continue to focus some of our newer and existing sales team members on major accounts and large deals, and as we operate our subscription-based business model, it may take longer, potentially significantly, for these sales team members to become fully productive, and there may also be an impact to the overall productivity of our sales team. As part of our overall efforts to improve our free cash flow performance, we have also proactively taken steps to increase our go-to-market productivity and over time, we intend to reduce our overall sales and marketing spend as a percentage of revenue. These measures include improving the efficiency of our demand generation spend, focusing on lower cost renewals, increasing leverage of our channel partners, and optimizing headcount in geographies based on market opportunities.
Investment in Research and Development and Engineering – We also intend, in the long term, to grow our global research and development and engineering teams to enhance our solutions, including our newer subscription-based products, improve integration with new and existing ecosystem partners and broaden the range of technologies and features available through our platform.
We believe that these investments will contribute to our long-term growth, although they may adversely affect our profitability in the near term.
Our Subscription-Based Business Model
We operate a subscription-based business model to provide our customers with the flexibility to choose the licensing that works best for them based on their specific business needs. A subscription-based business model means one in which our products, including associated support and entitlement arrangements, are sold with a defined term. Subscription-based sales consist of subscription term-based licenses and offerings with ongoing performance obligations, including software entitlement and support subscriptions and cloud-based SaaS offerings. Revenue from subscription term-based licenses is generally recognized upfront upon transfer of control to the customer, which happens when we make the software available to the customer. Accordingly, any decline in average contract durations associated with our subscription term-based licenses would negatively impact our topline results. Revenue from software entitlement and support subscription and cloud-based SaaS offerings is recognized ratably over the contractual service period. Accordingly, any decline in new or renewed subscriptions in any one fiscal quarter may not be fully or immediately reflected in our revenue for that fiscal quarter. For additional information on revenue recognition, see Note 3 of Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
42
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
Market Adoption of Our Products
The public cloud and, more recently, hybrid cloud paradigms, have changed IT buyer expectations about the simplicity, agility, scalability, portability and pay-as-you-grow economics of IT resources, which represent a major architectural shift and business model evolution. A key focus of our sales and marketing efforts is creating market awareness about the benefits of our enterprise cloud platform. This includes our newer products outside of our core hyperconverged infrastructure offering, both as compared to traditional datacenter architectures as well as the public cloud, particularly as we continue to pursue large enterprises and mission critical workloads. The broad nature of the technology shift that our enterprise cloud platform represents and the relationships our end customers have with existing IT vendors sometimes lead to unpredictable sales cycles. We hope to compress and stabilize these sales cycles as market adoption increases, as we gain leverage with our channel partners, as we continue to educate the market about our subscription-based business model and as our sales and marketing efforts evolve. Our business and operating results will be significantly affected by the degree to and speed with which organizations adopt our enterprise cloud platform.
Leveraging Partners
We plan to continue to leverage our relationships with our channel and OEM partners and expand our network of cloud and ecosystem partners, all of which help to drive the adoption and sale of our solutions with our end customers. We sell our solutions primarily through our partners, and our solutions primarily run on hardware appliances which are purchased from our channel or OEM partners. We believe that increasing channel leverage, particularly as we expand our focus on opportunities in commercial accounts, by investing in sales enablement and co-marketing with our channel and OEM partners in the long term will extend and improve our engagement with a broad set of end customers. Our reliance on manufacturers, including our channel and OEM partners, to produce the hardware appliances on which our software runs exposes us to supply chain delays, which impair our ability to provide services to end customers in a timely manner. Our business and results of operations will be significantly affected by our success in leveraging our relationships with our channel and OEM partners and expanding our network of cloud and ecosystem partners.
Customer Retention and Expansion
Our end customers typically deploy our technology for a specific workload initially. After a new end customer's initial order, which includes the product and associated software entitlement and support subscription and services, we focus on expanding our footprint by serving more workloads. We also generate recurring revenue from our software entitlement and support subscription renewals, and given our transition to a subscription-focused business model, software and support renewals will have an increasing significance for our future revenue streams as existing subscriptions come up for renewal. We view continued purchases and upgrades as critical drivers of our success, as the sales cycles are typically shorter as compared to new end customer deployments, and selling efforts are typically less. As of October 31, 2023, approximately 74% of our end customers who have been with us for 18 months or longer have made a repeat purchase, which is defined as any purchase activity, including renewals of term-based licenses or software entitlement and support subscription renewals, after the initial purchase. Additionally, end customers who have been with us for 18 months or longer have total lifetime orders, including the initial order, in an amount that is more than 8.0x greater, on average, than their initial order. This number increases to approximately 26.3x, on average, for Global 2000 end customers who have been with us for 18 months or longer as of October 31, 2023. These multiples exclude the effect of one end customer who had a very large and irregular purchase pattern that we believe is not representative of the purchase patterns of all of our other end customers.
Our business and operating results will depend on our ability to retain and sell additional solutions to our existing and future base of end customers. Our ability to obtain new and retain existing customers will in turn depend in part on a number of factors. These factors include our ability to effectively maintain existing and future customer relationships, continue to innovate by adding new functionality and improving usability of our solutions in a manner that addresses our end customers’ needs and requirements, and optimally price our solutions in light of marketplace conditions, competition, our costs and customer demand. Furthermore, our transition to a subscription-based business model and product transitions may cause concerns among our customer base, including concerns regarding changes to pricing over time, and may also result in confusion among new and existing end customers, for example, regarding our pricing models. Such concerns and/or confusion can slow adoption and renewal rates among our current and future customer base.
43
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
Components of Our Results of Operations
Revenue
We generate revenue primarily from the sale of our enterprise cloud platform, which can be deployed on a variety of qualified hardware platforms or, in the case of our cloud-based SaaS offerings, via hosted service or delivered pre-installed on an appliance that is configured to order. Non-portable software licenses are delivered or sold alongside configured-to-order appliances and can be used over the life of the associated appliance.
Our subscription term-based licenses are sold separately, or can be sold alongside configured-to-order appliances. Our subscription term-based licenses typically have a term of one to five years. Our cloud-based SaaS subscriptions have terms extending up to five years.
Configured-to-order appliances, including our Nutanix-branded NX hardware line, can be purchased from one of our channel partners, OEMs or, in limited cases, directly from Nutanix. Our enterprise cloud platform typically includes one or more years of support and entitlements, which provides customers with the right to software upgrades and enhancements as well as technical support. Our platform is primarily sold through channel partners and OEMs. Revenue is recognized net of sales tax and withholding tax.
Product revenue — Product revenue primarily consists of software revenue. A majority of our product revenue is generated from the sale of our enterprise cloud operating system. We also sell renewals of previously purchased software licenses and SaaS offerings. Revenue from our software products is generally recognized upon transfer of control to the customer, which is typically upon shipment for sales including a hardware appliance, upon making the software available to the customer when not sold with an appliance or as services are performed with SaaS offerings. In transactions where the hardware appliance is purchased directly from Nutanix, we consider ourselves to be the principal in the transaction and we record revenue and costs of goods sold on a gross basis.
Support, entitlements and other services revenue — We generate our support, entitlements and other services revenue primarily from software entitlement and support subscriptions, which include the right to software upgrades and enhancements as well as technical support. The majority of our product sales are sold in conjunction with software entitlement and support subscriptions, with terms ranging from one to five years. Occasionally, we also sell professional services with our products. We recognize revenue from software entitlement and support contracts ratably over the contractual service period, which typically commences upon transfer of control of the corresponding products to the customer. We recognize revenue related to professional services as they are performed.
Cost of Revenue
Cost of product revenue — Cost of product revenue consists of costs paid to third-party OEM partners, hardware costs, personnel costs associated with our operations function, consisting of salaries, benefits, bonuses and stock-based compensation, cloud-based costs associated with our SaaS offerings, and allocated costs, consisting of certain facilities, depreciation and amortization, recruiting and information technology costs allocated based on headcount.
Cost of support, entitlements and other services revenue — Cost of support, entitlements and other services revenue includes personnel and operating costs associated with our global customer support organization, as well as allocated costs. We expect our cost of support, entitlements and other services revenue to increase in absolute dollars as our support, entitlements and other services revenue increases.
Operating Expenses
Our operating expenses consist of sales and marketing, research and development and general and administrative expenses. The largest component of our operating expenses is personnel costs. Personnel costs consist of wages, benefits, bonuses and, with respect to sales and marketing expenses, sales commissions.
44
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
Sales and marketing — Sales and marketing expense consists primarily of personnel costs. Sales and marketing expense also includes sales commissions, costs for promotional activities and other marketing costs, travel costs and costs associated with demonstration units, including depreciation and allocated costs. Commissions are deferred and recognized as we recognize the associated revenue. We expect sales and marketing expense to continue, in the long term, to increase in absolute dollars as part of our long-term plans to invest in our growth. However, as part of our overall efforts to improve our operating cash flow performance, we have also proactively taken steps to increase our go-to-market productivity and over time, we intend to reduce our overall sales and marketing spend as a percentage of revenue. As we continue to recruit additional sales representatives, it will take time to train and ramp them to full productivity. As a result, our sales and marketing expense may fluctuate.
Research and development — Research and development ("R&D") expense consists primarily of personnel costs, as well as other direct and allocated costs. We have devoted our product development efforts primarily to enhancing the functionality and expanding the capabilities of our solutions. R&D costs are expensed as incurred, unless they meet the criteria for capitalization. We expect R&D expense, in the long term, to increase in absolute dollars as part of our long-term plans to invest in our future products and services, including our newer subscription-based products, although R&D expense may fluctuate as a percentage of total revenue and, on an absolute basis, from quarter to quarter.
General and administrative — General and administrative ("G&A") expense consists primarily of personnel costs, which include our executive, finance, human resources and legal organizations. G&A expense also includes outside professional services, which consists primarily of legal, accounting and other consulting costs, as well as insurance and other costs associated with being a public company and allocated costs. We expect G&A expense, in the long term, to increase in absolute dollars, particularly due to additional legal, accounting, insurance and other costs associated with our growth, although G&A expense may fluctuate as a percentage of total revenue and, on an absolute basis, from quarter to quarter.
Other Income (Expense), Net
Other income (expense), net consists primarily of interest income and expense, which includes the amortization of the debt discount and debt issuance costs associated with our previously outstanding 0% convertible senior notes due 2023 (the "2023 Notes"), our 2.50% convertible senior notes due 2026 (the "2026 Notes") and our 0.25% convertible senior notes due 2027 (the "2027 Notes"), changes in the fair value of the derivative liability associated with the 2026 Notes, non-cash interest expense on the 2026 Notes, the amortization of the debt discount on the 2026 Notes, interest expense on the 2027 Notes, debt extinguishment costs, interest income related to our short-term investments, and foreign currency exchange gains or losses.
Provision for Income Taxes
Provision for income taxes consists primarily of income taxes for certain foreign jurisdictions in which we conduct business and state income taxes in the United States. We have recorded a full valuation allowance related to our federal and state net operating losses and other net deferred tax assets and a partial valuation allowance related to certain foreign net operating losses due to the uncertainty of the ultimate realization of the future benefits of those assets.
45
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
Results of Operations
The following tables set forth our condensed consolidated results of operations in dollars and as a percentage of total revenue for the periods presented. The period-to-period comparison of results is not necessarily indicative of results for future periods.
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands) |
|
|||||
Revenue: |
|
|
|
|
|
|
||
Product |
|
$ |
208,574 |
|
|
$ |
246,922 |
|
Support, entitlements and other services |
|
|
225,035 |
|
|
|
264,132 |
|
Total revenue |
|
|
433,609 |
|
|
|
511,054 |
|
Cost of revenue: |
|
|
|
|
|
|
||
Product (1)(2) |
|
|
12,516 |
|
|
|
10,234 |
|
Support, entitlements and other services (1) |
|
|
69,979 |
|
|
|
71,725 |
|
Total cost of revenue |
|
|
82,495 |
|
|
|
81,959 |
|
Gross profit |
|
|
351,114 |
|
|
|
429,095 |
|
Operating expenses: |
|
|
|
|
|
|
||
Sales and marketing (1)(2) |
|
|
236,222 |
|
|
|
235,323 |
|
Research and development (1) |
|
|
149,443 |
|
|
|
151,975 |
|
General and administrative (1) |
|
|
46,104 |
|
|
|
47,503 |
|
Total operating expenses |
|
|
431,769 |
|
|
|
434,801 |
|
Loss from operations |
|
|
(80,655 |
) |
|
|
(5,706 |
) |
Other expense, net |
|
|
(13,416 |
) |
|
|
(5,275 |
) |
Loss before provision for income taxes |
|
|
(94,071 |
) |
|
|
(10,981 |
) |
Provision for income taxes |
|
|
5,443 |
|
|
|
4,872 |
|
Net loss |
|
$ |
(99,514 |
) |
|
$ |
(15,853 |
) |
|
|
|
|
|
|
|
||
(1) Includes stock-based compensation expense as |
|
|
|
|
|
|
||
Product cost of revenue |
|
$ |
2,159 |
|
|
$ |
1,928 |
|
Support, entitlements and other services cost of revenue |
|
|
5,346 |
|
|
|
7,116 |
|
Sales and marketing |
|
|
20,472 |
|
|
|
21,471 |
|
Research and development |
|
|
38,622 |
|
|
|
38,404 |
|
General and administrative |
|
|
14,356 |
|
|
|
15,079 |
|
Total stock-based compensation expense |
|
$ |
80,955 |
|
|
$ |
83,998 |
|
|
|
|
|
|
|
|
||
(2) Includes amortization of intangible assets as follows: |
|
|
|
|
|
|
||
Product cost of revenue |
|
$ |
2,810 |
|
|
$ |
1,111 |
|
Sales and marketing |
|
|
349 |
|
|
|
37 |
|
Total amortization of intangible assets |
|
$ |
3,159 |
|
|
$ |
1,148 |
|
46
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
|
|
Three Months Ended |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(as a percentage of total revenue) |
|
|||||
Revenue: |
|
|
|
|
|
|
||
Product |
|
|
48.1 |
% |
|
|
48.3 |
% |
Support, entitlements and other services |
|
|
51.9 |
% |
|
|
51.7 |
% |
Total revenue |
|
|
100.0 |
% |
|
|
100.0 |
% |
Cost of revenue: |
|
|
|
|
|
|
||
Product |
|
|
2.9 |
% |
|
|
2.0 |
% |
Support, entitlements and other services |
|
|
16.1 |
% |
|
|
14.0 |
% |
Total cost of revenue |
|
|
19.0 |
% |
|
|
16.0 |
% |
Gross profit |
|
|
81.0 |
% |
|
|
84.0 |
% |
Operating expenses: |
|
|
|
|
|
|
||
Sales and marketing |
|
|
54.5 |
% |
|
|
46.0 |
% |
Research and development |
|
|
34.5 |
% |
|
|
29.7 |
% |
General and administrative |
|
|
10.6 |
% |
|
|
9.3 |
% |
Total operating expenses |
|
|
99.6 |
% |
|
|
85.0 |
% |
Loss from operations |
|
|
(18.6 |
)% |
|
|
(1.0 |
)% |
Other expense, net |
|
|
(3.1 |
)% |
|
|
(1.0 |
)% |
Loss before provision for income taxes |
|
|
(21.7 |
)% |
|
|
(2.0 |
)% |
Provision for income taxes |
|
|
1.3 |
% |
|
|
1.0 |
% |
Net loss |
|
|
(23.0 |
)% |
|
|
(3.0 |
)% |
47
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
Comparison of the Three Months Ended October 31, 2022 and 2023
Revenue
|
|
Three Months Ended |
|
|
Change |
|
||||||||||
|
|
2022 |
|
|
2023 |
|
|
$ |
|
|
% |
|
||||
|
|
(in thousands, except percentages) |
|
|||||||||||||
Product |
|
$ |
208,574 |
|
|
$ |
246,922 |
|
|
$ |
38,348 |
|
|
|
18 |
% |
Support, entitlements |
|
|
225,035 |
|
|
|
264,132 |
|
|
|
39,097 |
|
|
|
17 |
% |
Total revenue |
|
$ |
433,609 |
|
|
$ |
511,054 |
|
|
$ |
77,445 |
|
|
|
18 |
% |
|
|
Three Months Ended |
|
|
Change |
|
||||||||||
|
|
2022 |
|
|
2023 |
|
|
$ |
|
|
% |
|
||||
|
|
(in thousands, except percentages) |
|
|||||||||||||
U.S. |
|
$ |
255,730 |
|
|
$ |
290,274 |
|
|
$ |
34,544 |
|
|
|
14 |
% |
Europe, the Middle |
|
|
100,253 |
|
|
|
124,584 |
|
|
|
24,331 |
|
|
|
24 |
% |
Asia Pacific |
|
|
69,103 |
|
|
|
83,112 |
|
|
|
14,009 |
|
|
|
20 |
% |
Other Americas |
|
|
8,523 |
|
|
|
13,084 |
|
|
|
4,561 |
|
|
|
54 |
% |
Total revenue |
|
$ |
433,609 |
|
|
$ |
511,054 |
|
|
$ |
77,445 |
|
|
|
18 |
% |
The increase in product revenue for the three months ended October 31, 2023, as compared to the prior year period, was due primarily to increases in software revenue resulting from growth in software renewals due to an increased adoption of our products, partially offset by the impact of the shorter average contract durations. For the three months ended October 31, 2022, the total average contract duration was approximately 3.0 years. For the three months ended October 31, 2023, the total average contract duration was approximately 2.9 years. Total average contract duration represents the dollar-weighted term across all subscription and life-of-device contracts billed during the period, using an assumed term of five years for licenses without a specified term, such as life-of-device licenses.
Support, entitlements and other services revenue increased for the three months ended October 31, 2023, as compared to the prior year period, in conjunction with the growth of our end customer base and the related software entitlement and support subscription contracts and renewals.
Cost of Revenue and Gross Margin
|
|
Three Months Ended |
|
|
Change |
|
||||||||||
|
|
2022 |
|
|
2023 |
|
|
$ |
|
|
% |
|
||||
|
|
(in thousands, except percentages) |
|
|||||||||||||
Cost of product revenue |
|
$ |
12,516 |
|
|
$ |
10,234 |
|
|
$ |
(2,282 |
) |
|
|
(18 |
)% |
Product gross margin |
|
|
94.0 |
% |
|
|
95.9 |
% |
|
|
|
|
|
|
||
Cost of support, |
|
$ |
69,979 |
|
|
$ |
71,725 |
|
|
$ |
1,746 |
|
|
|
2 |
% |
Support, entitlements |
|
|
68.9 |
% |
|
|
72.8 |
% |
|
|
|
|
|
|
||
Total gross margin |
|
|
81.0 |
% |
|
|
84.0 |
% |
|
|
|
|
|
|
Cost of product revenue
Cost of product revenue decreased for the three months ended October 31, 2023, as compared to the prior year period, due primarily to a decrease in amortization expense resulting from acquired intangible assets starting to reach the end of their useful lives. Slight fluctuations in hardware revenue and cost of product revenue are anticipated, as we expect to continue selling small amounts of hardware for the foreseeable future.
Product gross margin increased by 1.9 percentage points for the three months ended October 31, 2023, as compared to the prior year period, due primarily to the higher mix of software revenue, as we continued to focus on more software-only transactions, which have a higher margin as compared to hardware sales.
48
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
Cost of support, entitlements and other services revenue
Cost of support, entitlements and other services revenue increased for the three months ended October 31, 2023, as compared to the prior year period, due primarily to higher personnel-related costs, resulting from growth in our global customer support organization.
Support, entitlements and other services gross margin increased by 3.9 percentage points for the three months ended October 31, 2023, as compared to the prior year period, due primarily to support, entitlements and other services revenue growing at a higher rate than personnel-related costs.
Operating Expenses
Sales and marketing
|
|
Three Months Ended |
|
|
Change |
|
||||||||||
|
|
2022 |
|
|
2023 |
|
|
$ |
|
|
% |
|
||||
|
|
(in thousands, except percentages) |
|
|||||||||||||
Sales and marketing |
|
$ |
236,222 |
|
|
$ |
235,323 |
|
|
$ |
(899 |
) |
|
|
(0 |
)% |
Percent of total revenue |
|
|
54.5 |
% |
|
|
46.0 |
% |
|
|
|
|
|
|
Sales and marketing expense decreased for the three months ended October 31, 2023, as compared to the prior year period, due primarily to lower commissions expense resulting from changes to our commission plans for fiscal 2024.
Research and development
|
|
Three Months Ended |
|
|
Change |
|
||||||||||
|
|
2022 |
|
|
2023 |
|
|
$ |
|
|
% |
|
||||
|
|
(in thousands, except percentages) |
|
|||||||||||||
Research and development |
|
$ |
149,443 |
|
|
$ |
151,975 |
|
|
$ |
2,532 |
|
|
|
2 |
% |
Percent of total revenue |
|
|
34.5 |
% |
|
|
29.7 |
% |
|
|
|
|
|
|
Research and development expense increased for the three months ended October 31, 2023, as compared to the prior year period, due primarily to higher personnel-related costs resulting from growth in our R&D headcount, partially offset by decreases in technical costs.
General and administrative
|
|
Three Months Ended |
|
|
Change |
|
||||||||||
|
|
2022 |
|
|
2023 |
|
|
$ |
|
|
% |
|
||||
|
|
(in thousands, except percentages) |
|
|||||||||||||
General and administrative |
|
$ |
46,104 |
|
|
$ |
47,503 |
|
|
$ |
1,399 |
|
|
|
3 |
% |
Percent of total revenue |
|
|
10.6 |
% |
|
|
9.3 |
% |
|
|
|
|
|
|
General and administrative expense increased for the three months ended October 31, 2023, as compared to the prior year period, due primarily to higher personnel-related costs, including stock-based compensation expense, as well as an increase in technical costs, partially offset by lower legal costs.
49
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
Other Expense, Net
|
|
Three Months Ended |
|
|
Change |
|
||||||||||
|
|
2022 |
|
|
2023 |
|
|
$ |
|
|
% |
|
||||
|
|
(in thousands, except percentages) |
|
|||||||||||||
Interest income, net |
|
$ |
5,512 |
|
|
$ |
15,386 |
|
|
$ |
(9,874 |
) |
|
|
(179 |
)% |
Amortization of debt |
|
|
(15,730 |
) |
|
|
(16,347 |
) |
|
|
617 |
|
|
|
4 |
% |
Other |
|
|
(3,198 |
) |
|
|
(4,314 |
) |
|
|
1,116 |
|
|
|
35 |
% |
Other expense, net |
|
$ |
(13,416 |
) |
|
$ |
(5,275 |
) |
|
$ |
(8,141 |
) |
|
|
(61 |
)% |
Other expense, net decreased for the three months ended October 31, 2023, as compared to the prior year period, due primarily to increases in interest income on our investments.
Provision for Income Taxes
|
|
Three Months Ended |
|
|
Change |
|
||||||||||
|
|
2022 |
|
|
2023 |
|
|
$ |
|
|
% |
|
||||
|
|
(in thousands, except percentages) |
|
|||||||||||||
Provision for income taxes |
|
$ |
5,443 |
|
|
$ |
4,872 |
|
|
$ |
(571 |
) |
|
|
(10 |
)% |
The decrease in the income tax provision for the three months ended October 31, 2023, as compared to the prior year period, was due primarily to excess tax benefits on stock options and restricted stock units exercised in the current period. We continue to maintain a full valuation allowance on our U.S. federal and state deferred tax assets and a partial valuation allowance related to certain foreign net operating losses.
Liquidity and Capital Resources
Our principal sources of liquidity were cash, cash equivalents, and marketable securities and net accounts receivable. As of October 31, 2023, we had $612.5 million of cash and cash equivalents, $2.2 million of restricted cash and $958.7 million of short-term investments, which were held for general corporate purposes. Our cash, cash equivalents and short-term investments primarily consist of bank deposits, money market accounts and highly rated debt instruments of the U.S. government and its agencies and debt instruments of highly rated corporations. As of October 31, 2023, we had accounts receivable of $133.7 million, net of allowances of $1.4 million.
In January 2018, we issued convertible senior notes with a 0% interest rate for an aggregate principal amount of $575.0 million. In September 2021, we entered into privately negotiated exchange and note repurchase transactions, after which $145.7 million in aggregate principal amount of 2023 Notes remained outstanding. In January 2023, we settled the 2023 Notes in full at maturity with a cash payment of $145.7 million. For additional information, see Note 6 of Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
In September 2020, we issued $750.0 million in aggregate principal amount of 2.50% convertible senior notes due 2026 to BCPE Nucleon (DE) SPV, LP, an entity affiliated with Bain Capital, LP. For additional information, see Note 6 of Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
In September 2021, we issued convertible senior notes with a 0.25% interest rate for an aggregate principal amount of $575.0 million due 2027, of which $477.3 million in principal amount was issued in exchange for approximately $416.5 million principal amount of the 2023 Notes and the remaining $97.7 million in principal amount was issued for cash. There are no required principal payments on the 2027 Notes prior to their maturity. For additional information, see Note 6 of Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
50
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
Due to investments in our business as well as the potential cash flow impacts resulting from our transition to a subscription-based business model, our operating and free cash flow may continue to fluctuate during the next 12 months. Notwithstanding that fact, we believe that our cash and cash equivalents and short-term investments will be sufficient to meet our anticipated cash needs for working capital, including share repurchases, and capital expenditures for at least the next 12 months. Our future capital requirements will depend on many factors, including our growth rate, the timing and extent of spending to support development efforts, the expansion of sales and marketing activities, the introduction of new and enhanced product and service offerings, the continuing market acceptance of our products, our end customers and partners, and the economy, and the timing of and extent to which our customers transition to shorter-term contracts or request to only pay for the initial term of multi-year contracts as a result of our transition to a subscription-based business model.
Capital Return
In August 2023, our Board of Directors authorized the repurchase of up to $350.0 million of our Class A common stock. Repurchases will be funded from available working capital and may be made at management’s discretion from time to time. The authorization has no fixed expiration date and does not obligate us to repurchase any specified number or dollar value of shares. The program may be modified, suspended or discontinued at any time. For more information on the share repurchase program, refer to Note 9 of Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
Cash Flows
The following table summarizes our cash flows for the periods presented:
|
|
Three Months Ended October 31, |
|
|||||
|
|
2022 |
|
|
2023 |
|
||
|
|
(in thousands) |
|
|||||
Net cash provided by operating activities |
|
$ |
65,513 |
|
|
$ |
145,473 |
|
Net cash used in investing activities |
|
|
(8,237 |
) |
|
|
(42,218 |
) |
Net cash provided by (used in) financing activities |
|
|
20,330 |
|
|
|
(4,367 |
) |
Net increase in cash, cash equivalents and restricted cash |
|
$ |
77,606 |
|
|
$ |
98,888 |
|
Cash Flows from Operating Activities
Net cash provided by operating activities was $145.5 million for the three months ended October 31, 2023, compared to $65.5 million for the three months ended October 31, 2022. The increase in cash provided by operating activities for the three months ended October 31, 2023 was due primarily to the decrease in our net loss from operations.
Cash Flows from Investing Activities
Net cash used in investing activities of $8.2 million for the three months ended October 31, 2022 included $256.2 million of short-term investment purchases and $19.7 million of purchases of property and equipment, partially offset by $267.7 million of maturities of short-term investments.
Net cash used in investing activities of $42.2 million for the three months ended October 31, 2023 included $278.2 million of short-term investment purchases and $13.0 million of purchases of property and equipment, partially offset by $249.0 million of maturities of short-term investments.
Cash Flows from Financing Activities
Net cash provided by financing activities of $20.3 million for the three months ended October 31, 2022 included $22.2 million of proceeds from the sale of shares through employee equity incentive plans, partially offset by $1.9 million of payments for finance lease obligations.
Net cash used in financing activities of $4.4 million for the three months ended October 31, 2023 included $17.5 million of repurchases of our Class A common stock and $0.6 million of payments for finance lease obligations, partially offset by $13.8 million of proceeds from the sale of shares through employee equity incentive plans.
51
NUTANIX, INC.
Management's Discussion and Analysis of Financial Condition and Results of Operations (Continued)
Material Cash Requirements and Other Obligations
The following table summarizes our material cash requirements and other obligations as of October 31, 2023:
|
|
Payments Due by Period |
|
|||||||||||||||||
|
|
Total |
|
|
Less than |
|
|
1 Year to |
|
|
3 to |
|
|
More than |
|
|||||
|
|
(in thousands) |
|
|||||||||||||||||
Principal amount payable on convertible senior notes (1) |
|
$ |
1,385,235 |
|
|
$ |
116 |
|
|
$ |
810,119 |
|
|
$ |
575,000 |
|
|
$ |
— |
|
Operating leases (undiscounted basis) (2) |
|
|
120,160 |
|
|
|
32,200 |
|
|
|
35,424 |
|
|
|
30,985 |
|
|
|
21,551 |
|
Other commitments (3) |
|
|
107,110 |
|
|
|
95,393 |
|
|
|
9,519 |
|
|
|
2,198 |
|
|
|
— |
|
Guarantees with contract manufacturers |
|
|
53,649 |
|
|
|
53,649 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Total |
|
$ |
1,666,154 |
|
|
$ |
181,358 |
|
|
$ |
855,062 |
|
|
$ |
608,183 |
|
|
$ |
21,551 |
|
From time to time, in the normal course of business, we make commitments with our contract manufacturers to ensure them a minimum level of financial consideration for their investment in our joint solutions. These commitments are based on revenue targets or on-hand inventory and non-cancelable purchase orders for non-standard components. We record a charge related to these items when we determine that it is probable a loss will be incurred and we are able to estimate the amount of the loss. Our historical charges have not been material.
As of October 31, 2023, we had accrued liabilities related to uncertain tax positions, which are reflected on our condensed consolidated balance sheet. These accrued liabilities are not reflected in the contractual obligations disclosed in the table above, as it is uncertain if or when such amounts will ultimately be settled.
Critical Accounting Policies and Estimates
Our condensed consolidated financial statements are prepared in accordance with U.S. GAAP. The preparation of these condensed consolidated financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the applicable periods. We evaluate our estimates, assumptions and judgments on an ongoing basis. Our estimates, assumptions and judgments are based on historical experience and various other factors that we believe to be reasonable under the circumstances. Different assumptions and judgments would change the estimates used in the preparation of our condensed consolidated financial statements, which, in turn, could change the results from those reported.
There have been no material changes to our critical accounting policies and estimates as compared to those described in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023.
Recent Accounting Pronouncements
See Note 1 of Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for a full description of recent accounting pronouncements.
52
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We have operations both within the United States and internationally and we are exposed to market risk in the ordinary course of business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in foreign currency exchange rates and interest rates.
Foreign Currency Risk
Our condensed consolidated results of operations and cash flows are subject to fluctuations due to changes in foreign currency exchange rates. Historically, our revenue contracts have been denominated in U.S. dollars. Our expenses are generally denominated in the currencies of the countries where our operations are located. To date, we have not entered into any hedging arrangements with respect to foreign currency risk or other derivative instruments. In the event our foreign sales and expenses increase, our operating results may be more significantly affected by foreign currency exchange rate fluctuations, which can affect our operating income or loss. The effect of a hypothetical 10% change in foreign currency exchange rates on our non-U.S. dollar monetary assets and liabilities would not have had a material impact on our historical condensed consolidated financial statements. Foreign currency transaction gains and losses and exchange rate fluctuations have not been material to our condensed consolidated financial statements.
A hypothetical 10% decrease in the U.S. dollar against other currencies would result in an increase in our operating loss of approximately $19.0 million and $15.9 million for the three months ended October 31, 2022 and 2023, respectively. The decrease in this hypothetical change is due to a decrease in our expenses denominated in foreign currencies. This analysis disregards the possibilities that rates can move in opposite directions and that losses from one geographic area may be offset by gains from another geographic area.
Interest Rate Risk
Our investment objective is to conserve capital and maintain liquidity to support our operations; therefore, we generally invest in highly liquid securities, consisting primarily of bank deposits, money market funds, commercial paper, U.S. government securities and corporate bonds. Such fixed and floating interest-earning instruments carry a degree of interest rate risk. The fair market value of fixed income securities may be adversely impacted by a rise in interest rates, while floating rate securities may produce less income than predicted if interest rates fall. Due to the short-term nature of our investment portfolio, we do not believe an immediate 10% increase or decrease in interest rates would have a material effect on the fair market value of our portfolio. Therefore, we do not expect our operating results or cash flows to be materially affected by a sudden change in interest rates.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer and our principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended ("Exchange Act")). As initially disclosed in our Annual Report on Form 10-K/A filed with the SEC on May 24, 2023, our management identified a material weakness in our internal control over financial reporting. As described below, while our management, with the oversight of the Audit Committee of our Board of Directors, has made significant progress toward remediating this material weakness, our management determined that this material weakness has not yet been fully remediated. Accordingly, based on our management’s evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of October 31, 2023. Notwithstanding this material weakness, our management concluded that our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q fairly present, in all material respects, our financial condition, results of operations and cash flows as of and for the periods presented in conformity with U.S. GAAP.
Previously Identified Material Weakness in Internal Control Over Financial Reporting
Based on the criteria set forth in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (the "COSO Framework"), our management identified control deficiencies, as previously disclosed, that, individually or in the aggregate, constitute a material weakness in our internal control over financial reporting. While our management, with the oversight of the Audit Committee of our Board of Directors, has made significant progress toward remediating the material weakness, the material weakness has not been fully remediated as of October 31, 2023.
53
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company's annual or interim financial statements will not be prevented or detected on a timely basis. The material weakness identified by management primarily relates to design deficiencies in the information and communication component of the COSO Framework, that also impacted the design and operating effectiveness of elements of the risk assessment and other components. In particular, we determined that our controls were not designed and operating effectively to provide the information necessary for our risk assessment process to identify non-compliant use of third-party software as a risk of material misstatement in our financial reporting and we did not effectively reinforce the importance of raising concerns about perceived unethical conduct in a timely manner. These control deficiencies, individually or in the aggregate, create a reasonable possibility that a material misstatement of our consolidated financial statements would not be prevented or detected on a timely basis, and constitute a material weakness in our internal control over financial reporting.
This material weakness resulted in an immaterial error in the reporting of expenses for software licenses and support for each prior period beginning in August 2014, which we have corrected prospectively as we issue future financial statements, as disclosed in Note 2 of Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q. We have evaluated the materiality of this error and determined that the impact is not material to our previously issued financial statements.
Status of Remediation Efforts to Address Material Weakness
Our management and the Audit Committee of our Board of Directors are committed to remediating the material weakness and strengthening our overall internal control over financial reporting. To this end, our management, with oversight from the Audit Committee, has implemented all of the remedial measures outlined in the remediation plan initially disclosed in our Annual Report on Form 10-K/A filed with the SEC on May 24, 2023. Specifically, we have implemented the following remedial measures as outlined in the remediation plan:
Our management believes that the remediation measures described above will remediate the material weakness and strengthen our overall internal control over financial reporting. While we have implemented all of the remedial measures described above, we are still in the process of testing the applicable remediated controls. Accordingly, our management determined that this material weakness has not yet been fully remediated as of October 31, 2023. The material weakness will not be considered remediated until the applicable remediated controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. As our management continues to evaluate and work to enhance our internal control over financial reporting, our management may take additional measures to address control deficiencies or we may modify some of the remediation measures described above.
54
Changes in Internal Control over Financial Reporting
Except for the remediation measures we have implemented to address the previously identified material weakness noted above, there was no change in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
55
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
The information set forth under the "Legal Proceedings" subheading in Note 8 of Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated herein by reference.
Item 1A. Risk Factors
You should carefully consider the risks and uncertainties described under the heading "Risk Factors" in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended July 31, 2023, which is incorporated herein by reference, together with all of the other information contained in this Quarterly Report on Form 10-Q, including our condensed consolidated financial statements and related notes, before making a decision to invest in our Class A common stock. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that affect our business. There have been no material changes from the risks and uncertainties previously disclosed under the "Risk Factors" section in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Unregistered Sales of Equity Securities
None.
Issuer Purchases of Equity Securities
The following table summarizes the share repurchase activity for the three months ended October 31, 2023:
Period |
|
Total Number of Shares Purchased |
|
|
Average Price Paid Per Share |
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1) |
|
|
Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs |
|
||||
|
|
(in thousands, except per share amounts) |
|
|||||||||||||
August 1 - 31, 2023 |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
350,000 |
|
September 1 - 30, 2023 |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
350,000 |
|
October 1 - 31, 2023 |
|
|
482 |
|
|
$ |
36.34 |
|
|
|
482 |
|
|
$ |
332,497 |
|
Total |
|
|
482 |
|
|
|
|
|
|
482 |
|
|
|
|
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
During the three months ended October 31, 2023,
56
Item 6. Exhibits
See the Exhibit Index below for a list of exhibits filed or furnished with this report, which Exhibit Index is incorporated herein by reference.
57
EXHIBIT INDEX
|
|
Incorporated by Reference |
|
|||
Number |
Exhibit Title |
Form |
File No. |
Exhibit |
Filing Date |
Filed Herewith |
10.1 |
|
|
|
|
X |
|
31.1 |
|
|
|
|
X |
|
31.2 |
|
|
|
|
X |
|
32.1* |
|
|
|
|
X |
|
32.2* |
|
|
|
|
X |
|
101.INS |
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XRBL tags are embedded within the Inline XBRL document |
|
|
|
|
X |
101.SCH |
XBRL Taxonomy Extension Schema Document |
|
|
|
|
X |
101.CAL |
XBRL Taxonomy Extension Calculation Linkbase Document |
|
|
|
|
X |
101. |
XBRL Taxonomy Extension Definition |
|
|
|
|
X |
101. |
XBRL Taxonomy Extension Label Linkbase |
|
|
|
|
X |
101.PRE |
XBRL Taxonomy Extension Presentation Linkbase Document |
|
|
|
|
X |
104 |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
|
|
|
|
X |
* These exhibits are furnished with this Quarterly Report on Form 10-Q and are not deemed filed with the Securities and Exchange Commission and are
not incorporated by reference in any filing of Nutanix, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as
amended, whether made before or after the date hereof and irrespective of any general incorporation language contained in such filings.
58
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
NUTANIX, INC. |
|
|
|
Date: December 7, 2023 |
|
/s/ Rukmini Sivaraman |
|
|
Rukmini Sivaraman |
|
|
Chief Financial Officer |
|
|
(Principal Financial Officer) |
59
Exhibit 10.1
THIRTEENTH AMENDMENT (1740 TECHNOLOGY)
THIS THIRTEENTH AMENDMENT (this "Amendment") is made and entered into as of November 16, 2023, by and between HUDSON 1740 TECHNOLOGY, LLC, a Delaware limited liability company ("Landlord"), and NUTANIX, INC., a Delaware corporation ("Tenant").
RECITALS
NOW, THEREFORE, in consideration of the above recitals which by this reference are incorporated herein, the mutual covenants and conditions contained herein and other valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Landlord and Tenant agree as follows:
the first (1st) floor of the Building and 236 rentable square feet of storage space located on the second floor of the Building (defined collectively as the "Second Expansion Space" in the Seventh Amendment); Suite 250 located on the second (2nd) floor of the Building (defined as the "Suite 250 Must Take Space" in the Seventh Amendment); Suite 460 located on the Fourth Floor of the Building (defined as the "Suite 460 Must Take Space" in the Seventh Amendment); and Suite 100 located on the first (1st) floor of the Building (defined as the "Suite 100 Must Take Space" in the Seventh Amendment); all as depicted on Exhibit G attached hereto.
-2-
Areas, subject to such reasonable rules and procedures as Landlord may establish from time to time. Notwithstanding any provision of the Lease to the contrary (including, without limitation Section 6.1(d) of the Original Lease), effective as of November 1, 2023, Landlord shall have no obligation to provide or pay for trash-disposal, janitorial, cleaning or pest-control services to the interior of the Premises. In addition, effective as of November 1, 2023, (a) Tenant (at its expense) shall provide day- porter services to the sport court adjacent to the Building ("Sport Court"), which day-porter-services ("Selective Day Porter Services") shall consist of the following tasks: picking up trash in the Sport Court, emptying garbage cans in the Sport Court in containers provided by Landlord for such purpose in the Common Areas ; and(b) Landlord shall have no obligation to provide or pay for the Selective Day Porter Services for the Sport Court. Landlord shall provide a day porter for four (4) hours per day to empty garbage in containers placed by Landlord in the Parking Facility and provide landscape/blower vacuum services for the Property, the costs of which shall be included in Expenses. From and after November 1, 2023, the Base Year (as applicable to each portion of the Premises) shall be adjusted to exclude the cost of services which will be provided by Tenant going forward under the terms of this Section 4.
Tenant may park in the Building parking facilities ("Parking Facility), upon the following terms and conditions. All of the parking spaces in the Parking Facility, except those depicted on Exhibit I attached hereto, shall be reserved for use by Tenant. Landlord shall not be liable to Tenant, nor shall this Lease be affected, if any parking is impaired by (or any parking charges are imposed as a result of) any Law. Tenant shall pay Landlord any fees, taxes or any other charges imposed by any governmental or quasi-governmental agency in connection with the parking Facility. Tenant shall comply with all rules and regulations established by Landlord from time to time for the orderly operation and use of the Parking Facility, including any sticker or other identification system and the prohibition of vehicle repair and maintenance activities in the Parking Facility. Tenant's use of the Parking Facility shall be at Tenant's sole risk, and Landlord shall have no liability for any personal injury or damage to or theft of any vehicles or other property occurring in the Parking Facility or otherwise in connection with any use of the Parking Facility by Tenant or its employees or invitees except to the extent such injury, damage, or theft is caused by the gross negligence or willful misconduct of Landlord or Landlord's employees, agents, or invitees. Subject to no less than thirty (30) days' prior written notice, Landlord may alter the size, configuration, design, layout or any other aspect of the Parking Facility, and, in connection therewith, temporarily deny or restrict access to the Parking Facility, in each case without abatement of Rent or liability to Tenant; provided in no event shall such alterations result in a reduction of parking spaces available to Tenant. Tenant's parking rights under this Section 24 are solely for the benefit of Tenant's employees and invitees and such rights are not be transferred without Landlord's prior consent, except pursuant to a Transfer permitted under Section 14.
-3-
Lease shall apply to occurrences in the Parking Facility. Accordingly, Tenant shall provide Landlord with an updated certificate of insurance showing that such insurance applies to the Parking Facility.
10.1 of the Original Lease. Notwithstanding the foregoing, (i) Landlord shall be permitted (at its sole option) to maintain a roving patrol security detail at the Property, and (ii) the cost thereof shall be considered an Expense; provided, however, that the foregoing shall not be deemed to mitigate Tenant's waiver set forth in Section 10.1(ii) of the Original Lease. From and after November 1, 2022, the Base Year (as applicable to each portion of the Premises) shall be adjusted to exclude the cost of the contract
-4-
with a security vendor to provide personnel to the Premises and the Building which will be provided by Tenant going forward.
12. The Single Tenant Amendment. Tenant hereby acknowledges and agrees, that at such time that Tenant has added to the Premises all of the remaining must-take space as provided in the Fifth Amendment and this Seventh Amendment, such that Tenant is effectively the only office tenant in the Building, Landlord may prepare and deliver to Tenant an amendment (the "Single Tenant Amendment") (a) shifting the obligation to provide and pay for janitorial services and security services to the Premises from Landlord to Tenant, and (b) decreasing the amount included for Expenses in the Base Year(s) then-applicable to various portions of the Premises to exclude the amount that Landlord reasonably determines it incurred to provide janitorial services and security service in the applicable Base Year(s). Tenant shall execute and return the Single Tenant Amendment to Landlord within fifteen
(15) days after receiving it, but Landlord shall be relieved of the obligation to provide and pay for janitorial service and security service to the Premises and the Expenses included in the Base Year(s) shall be adjusted whether or not the Single Tenant Amendment is executed.
18. Entry by Landlord. At all reasonable times and upon reasonable notice to Tenant, Landlord may enter the Premises to (i) inspect the Premises; (ii) show the Premises to prospective purchasers, current or prospective Security Holders or insurers, or, during the last twelve (12) months of the Term (or while an uncured Default exists), prospective tenants; (iii) post notices of responsibility; or (iv) perform maintenance, repairs or alterations. If reasonably necessary, Landlord may temporarily close any portion of the Premises to perform maintenance, repairs or alterations. Notwithstanding the foregoing, in an emergency, no notice shall be required, and Landlord may use any means it deems proper to open doors to and in the Premises. Except in an emergency, Landlord shall use reasonable efforts to minimize interference with Tenant's use of the Premises. No entry into or closure of any portion of the Premises pursuant to this Section 18 shall render Landlord liable to Tenant, constitute a constructive eviction, or excuse Tenant from any obligation hereunder.
-5-
any party delivering such a counterpart shall in all events deliver to the other party an original signature promptly upon request.
[Signatures Follow]
-6-
IN WITNESS WHEREOF, Landlord and Tenant have duly executed this Amendment as of the day and year first above written.
LANDLORD: HUDSON 1740 TECHNOLOGY, LLC,
a Delaware limited liability company
By: Hudson Pacific Properties, L.P., a Maryland limited partnership, its sole member
By: Hudson Pacific Properties, Inc., a Maryland corporation,
its general partner
By: /s/ Kenneth Young
Name: Kenneth Young
Title: Senior Vice President, Leasing
TENANT: NUTANIX, INC.,
a Delaware corporation
By: /s/ Prairie Padilla
Name: Prairie Padilla
Title: VP, Corporate Controller
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Rajiv Ramaswami, certify that:
Date: December 7, 2023 |
|
/s/ Rajiv Ramaswami |
|
|
Rajiv Ramaswami |
|
|
President and Chief Executive Officer |
|
|
(Principal Executive Officer) |
Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Rukmini Sivaraman, certify that:
Date: December 7, 2023 |
|
/s/ Rukmini Sivaraman |
|
|
Rukmini Sivaraman |
|
|
Chief Financial Officer |
|
|
(Principal Financial Officer) |
Exhibit 32.1
CERTIFICATION
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Rajiv Ramaswami, certify pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Nutanix, Inc. for the fiscal quarter ended October 31, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act and that the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Nutanix, Inc.
Date: December 7, 2023 |
|
/s/ Rajiv Ramaswami |
|
|
Rajiv Ramaswami |
|
|
President and Chief Executive Officer |
|
|
(Principal Executive Officer) |
Exhibit 32.2
CERTIFICATION
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Rukmini Sivaraman, certify pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Nutanix, Inc. for the fiscal quarter ended October 31, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act and that the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Nutanix, Inc.
Date: December 7, 2023 |
|
/s/ Rukmini Sivaraman |
|
|
Rukmini Sivaraman |
|
|
Chief Financial Officer |
|
|
(Principal Financial Officer) |